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Abstract 
 
Michael A Olaopa 
 
RESCUING A BROKEN HEART: 
A TALE OF TWO MODELS OF NEURAL CREST DEFICIENCY AND ITS 
IMPACT ON IN UTERO HEART FUNCTION AND 
EMBRYONIC SURVIVAL VIA THE BETA-ADRENERGIC PATHWAY 
 
Congenital heart defects occur in approximately one percent of births every year, 
which makes it the most frequently occurring congenital defect in patients. The 
aim of this project was to use two mutant neural crest (NC) mouse models to 
study the mechanisms underlying congenital heart failure in utero. The first 
mouse model was a Pax3 systemic knockout, which was lethal by mouse 
gestational day 14, and had appreciably reduced numbers of migratory NC cells. 
The second mouse model was a Wnt1Cre-mediated NC genetic cell ablation 
model, which was surprisingly viable and survived to birth, despite an apparent 
lack of migratory NC cells. The resultant data indicated that both mouse models 
had similar heart structural defects including persistent truncus arteriosus, which 
was due to fewer or no migratory cardiac NC cells. However, in utero heart 
function was appreciably perturbed in Pax3 mutants when compared to that of 
the ablated mutant model. The loss of embryonic cardiac function in Pax3 
mutants was directly attributed to a substantial decrease in the activity of the 
 vi
beta-adrenergic pathway. This was due to a lack of proper specification of trunk 
NC cells, leading to diminished levels of circulating catecholamine levels in the 
embryo. To definitively confirm this conclusion, poor cardiac function was 
successfully restored by pharmacological stimulation of the beta-adrenergic 
pathway via administration of isoproterenol and forskolin to pregnant dams, 
which led to embryonic survival of Pax3 mutants to birth. By comparison of these 
two mutant mouse models, perturbation in the beta-adrenergic pathway was 
identified as the underlying mechanism responsible for in utero heart failure and 
lethality in Pax3 mutant embryos. The results of this study are expected to be 
significant in developing future therapeutic targets for congenital heart failure in 
prenatal and newborn patients. 
 
 
 
 
Simon J. Conway, Ph.D., Chair 
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Chapter I: Introduction 
 
1. Neural crest development 
 
Neural crest (NC) cells are a multipotent and transient migratory lineage 
originating from the neuroepithelium, which borders the surface ectoderm and 
gives rise to the embryonic neural tube. NC cells can give rise to an array of 
different cell types, tissues, and organs [1]. For this reason, they are often 
referred to as the fourth germ layer of the developing embryo, in addition to the 
ectoderm, endoderm and mesoderm cell lineages. The derivatives of NC are 
considerably diverse in both function and structure. From the cardiovascular to 
the peripheral nervous systems, NC cells have been shown to be absolutely 
essential at very early stages during development for normal organogenesis to 
occur. In addition, they are important during in utero craniofacial, melanocyte, 
and gastrointestinal development, as well as postnatally as NC stem cells [2]. 
 
Different subpopulations of NC have been identified based on their rostrocaudal 
position of origin along the axis of the developing embryo, their specific 
properties, and the nature of their derivatives. The developing neural tube 
extends in a rostral to caudal direction beginning at the mid-diencephalon. As a 
result, NC cells have been broadly subdivided into cranial, cardiac, trunk and 
sacral NC’s. In mouse, the cranial and cardiac NC cells originate from the mid-
diencephalon to the fifth somite [3, 4]. Furthermore, the trunk and sacral NC cells 
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begin from the fifth somite to the caudal region of the neural tube [5]. In addition 
to location, the cranial and trunk NC’s also differ in functional properties. For 
instance, the cranial NC is ectomesenchymal, which means that it has the ability 
to give rise to mesenchymal derivatives, while the trunk NC does not. 
Alternatively, the trunk NC has the ability to regenerate, while the cranial NC 
does not. Interestingly, the cardiac NC originates from the mid-otic sulcus (the 
presumptive ear) to the third somite, which represents the caudal region of the 
cranial NC directly rostral to the beginning of the trunk NC [6]. As a result, the 
cardiac NC shares some properties of both cranial and trunk NC’s, including their 
respective abilities to generate ectomesenchyme and regenerate [5]. This project 
focuses primarily on the roles of both cardiac and trunk NC’s, and their 
importance to organ development. Specifically, I have explored their respective 
contributions to the cardiovascular and peripheral nervous systems, with 
emphasis on their functional and structural roles in cardiac and sympathoadrenal 
differentiation and stabilization (Figure 1).  
 
1.1. Neural crest formation and specification 
It is generally believed that the neural plate can induce formation of NC cells via 
interaction with the adjacent epidermis. Experiments done in avian embryos [7] 
demonstrated effectively that early or late stage neural plate tissue could give 
rise to NC cells. Furthermore, this induction occurred via interaction between the 
neural plate and the non-neural ectoderm. Although NC cells originate from a 
subpopulation of cells located between the developing neural and non-neural 
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ectoderm, studies have shown that these cells can give rise to other cell types as 
well, indicative of a higher developmental potential [8].  Thus, this suggests that 
signaling from the neural plate is important in initial induction and formation.  
 
Several families of proteins have been shown to be important in initial NC 
formation, including the BMP, FGF and Wnt families. BMP4 is expressed within 
the epidermis at the border of the neural plate, and several studies have 
demonstrated that BMP4 is important in early NC induction. BMP4 has been 
shown to be absolutely required for cultured neural plates to induce NC, even in 
the absence of ectoderm [9]. In addition, beads soaked with noggin, (a BMP 
antagonist) when placed in the region of the epidermis that borders the neural 
plate, leads to its expansion [8]. In Xenopus, FGFs may be required to induce 
mesoderm, from which NC can be induced [10]. However, the exact role of FGF 
signaling in NC induction is still being determined. Some studies have suggested 
that FGF signaling acts directly through modulation of noggin in order for early 
NC induction to occur [11]. Furthermore, Wnt activity has been shown to play a 
role as well. In the absence of Wnt signaling in chick embryos, neural crest 
marker expression is diminished or completely eliminated [12]. It is believed that 
initial Wnt expression is required for NC induction, and then subsequent 
downregulation of Wnt must occur in order for the NC cells to delaminate from 
neural tube. This downregulation may also be regulated by a BMP-dependent 
pathway [13].  
 
 3
2. CNC development 
 
The CNC is a subpopulation of NC that contributes to heart morphogenesis. In 
addition to providing all of the parasympathetic innervation of the heart [14], 
migratory CNC also contribute to the smooth muscle cells that surround the 
aortic arches and the mesenchymal cells that colonize the OFT.  Thus, improper 
specification or migration of CNC can lead to abnormal regression/persistence of 
AAA’s [5], which results in OFT defects such as PTA/VSD (Figure 1). 
 
2.1. AAA asymmetric remodeling 
Aortic arch arteries develop from endothelial strands within the arches, and 
connect the aortic sac and the dorsal aortas. In chick embryos, they begin as six 
symmetric pairs of arteries attached to the paired dorsal aorta. However, in 
mammals, there are only five symmetric pairs, which are remodeled to give rise 
to a separate ascending aorta [15]. Well-established reports [16] have clearly 
demonstrated that the cranial NC gives rise to 1st/2nd AAA, while CNC cells 
migrate and colonize 3rd/4th/6th AAA [17]. This occurs on their way to colonizing 
the aorticopulmonary septum of the OFT, where they coalesce into ridges of 
connective tissue [6]. Interestingly, the CNC cells are not required for the initial 
formation of the aortic arches, but are important for their final patterning [18] and 
stabilization [19]. These CNC cells migrate into each arch as it successively 
forms and then surround the endothelial cells that form the emerging arches. The 
role of CNC in stabilizing the arches is a very important one. In fact, stability of 
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target tissues and vessels appears to be a common function of both cardiac and 
trunk NC. 
 
In order for proper AAA remodeling to occur, the arteries must undergo a series 
of asymmetric regression and persistence (Figure 2). The 3rd arch arteries give 
rise to common carotid arteries, 4th arch arteries contribute to the formation of the 
distal part of the aortic arch, the brachiocephalic artery and a proximal part of the 
right subclavian artery, while the left 6th arch arteries contribute to the ductus 
arteriosus and the proximal parts of the pulmonary arteries [2]. In addition, the 
parathyroid and thyroid glands are derived from the endoderm of the third arches 
via interaction with cardiac NC cells [20]. Reciprocal interactions between the 
migratory cardiac NC cells and the surrounding endothelial cells of the arches 
have been shown to be important in arch artery remodeling as well. Endothelin-1 
(ET-1), which is expressed in the surrounding endothelial cells of the arches but 
not in the migratory CNC cells, has been shown to be involved in a complex 
signaling pathway that is required for normal arch remodeling to occur [21]. The 
migratory CNC cells are known to express ET-A (ET-1 receptor), and it is 
believed that proper signaling between the arches and the CNC cells as they 
migrate through them is important [5, 6] in order to have proper remodeling. 
Furthermore, mouse embryos which are deficient for either ET-1 or ET-A display 
defects in arch remodeling and alignment. Specifically, there is regression of 
arches 4 and 6, and these mice eventually die from other heart-related defects.  
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Certain growth factors have also recently been implicated in the remodeling 
process. Specifically, endothelial-specific expression of platelet-derived growth 
factor alpha (PDGFα) and activated (phosphophorylated) vascular endothelial 
growth factor receptor 2 (VEGFr2) have been shown to be important in the cells 
surrounding the left 6th arch artery, which continues to persist even as the right 
6th arch regresses [22]. This expression of growth factors was shown to be 
maintained by unilateral distribution of blood flow. It is still unclear what role CNC 
cells may play in this signaling pathway. However, CNC cell-specific expression 
of platelet-derived growth factor receptor alpha (PDGFrα) has been shown to be 
important in regulating smooth muscle cell differentiation [23], which surround the 
arches and play an important stabilization role. In addition, asymmetric 
expression of Pitx2 in the aortic arch mesoderm has been shown to be important 
for normal remodeling to occur. Loss of Pitx2c results in abnormal remodeling of 
the aortic arch vessels [24], due to poor communication between CNC cells and 
the endothelial cells surrounding the arteries. This provides another example of 
the importance of signaling between the CNC cells and the adjacent surrounding 
endothelial cells for proper AAA development and eventual OFT remodeling. 
 
2.2. OFT formation and remodeling 
The OFT is a common vessel exiting the heart, which during cardiac 
development is septated into the pulmonary artery and aorta. This leads to 
proper separation of pulmonic and systemic blood flow. Before septation, as a 
common vessel, it branches at the aortic sac into aortic arches 3, 4 and 6 [2, 5, 
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18]. CNC cells are known to play an important role in giving rise to the 
aorticopulmonary septum, which eventually divides the OFT. Extensive studies 
on the migration and colonization of the OFT by cardiac NC cells is now possible 
with the advent of transgenic mouse Cre lines, which allow Cre/loxP-mediated 
lineage traces to be performed. Several transgenic mouse Cre lines are now 
used to study cardiac NC cell migration, including the P0-cre, Wnt1-cre, Pax3-
cre, and PlexinA2-cre lines [4, 25, 26]. Based on these studies, we now have a 
more comprehensive image of the structural contribution of CNC cells and their 
derivatives to the OFT. 
 
The OFT cushions are initially acellular, and then become filled with cardiac jelly 
derived from a mixture of mesenchymal cells that migrate from the pharynx and 
endocardially-derived cells that have undergone epithelial to mesenchymal 
transformation. CNC cells also contribute to this mesenchymal population, by 
migrating via a pair of horseshoe-shaped prongs or condensed streams into the 
distal region of the OFT.  In mouse, the CNC cells do so via a subendocardial 
route, and they continue all the way to the distal conus of the OFT [2, 5]. During 
development, this CNC cell-derived mesenchymal population is gradually 
replaced by myocardium in a process known as myocardialization [27]. 
Myocardialization of the proximal OFT is important to form the muscular outlet 
septum of the heart and the atrioventricular canal septum. This process is 
believed to be regulated by Wnt family of proteins [28] via the Wnt-PCP pathway. 
These studies demonstrated that growth factors such as Wnt5a and Wnt11 are 
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required to be expressed in the OFT cushion mesenchyme in order for normal 
myocardialization to occur [29]. In addition, to the Wnt family, BMP and FGF 
family of proteins have been shown to be required in conjunction with other 
factors to induce normal myocardialization [30].  
 
The Wnt pathway has also been implicated in regulating the process of cell death 
of a subset of these CNC cells, which contribute to the conotruncal cushions. 
After septation is complete, they are believed to eventually undergo apoptosis 
[31]. These cells transiently express a Wnt receptor Frizzled-2 [32], suggesting a 
role in remodeling and patterning during septation. However, it is believed that 
some CNC cells can persist even after birth [4, 33], despite the massive 
apoptosis and rearrangement of cardiomyocytes that occurs after septation and 
during myocardialization. In addition to septation of the OFT, cardiac NC cells are 
also important in its elongation and eventual looping and correct alignment. 
Besides providing a structural framework for the outflow septum, the cardiac NC 
cells are also believed to be important in regulating cell-cell signaling between 
the pharynx, during addition of cells derived from the anterior heart field (AHF) to 
the OFT. In conjunction with these AHF-derived cell lineages, cardiac NC cells 
play a role in OFT elongation [34]. The derivatives of the AHF give rise to the 
myocardial cuff of the OFT, while the CNC cells give rise to the mesenchymal 
cell population in the cushions. As cells continue to be added to the caudal end 
of the OFT, the endocardial cushions spiral, leading to rotation of the outflow 
 8
septum and eventual realignment of the aorta in a posteriolateral direction and 
the pulmonary artery in an anteriomedial direction [35].  
 
Despite the significant progress that has been made regarding the structural and 
functional roles of cardiac NC cells in OFT remodeling, elongation and septation, 
still very little is known about what molecular factors are expressed within these 
cells post-migration as they undergo differentiation within the OFT cushions. The 
identification of a post-migratory marker of CNC cells will be both a significant 
and transformative discovery in the field of cardiovascular development. This 
could open the door to designing potential therapeutic targets for congenital heart 
defects and OFT remodeling anomalies associated with aberrant gene 
expression. Currently, there are several strategies being used to address this 
question, including the use of laser-capture and cell-sorting technologies to 
isolate and screen expression profiles of cells located in the cardiac crest-derived 
distal region of the OFT. 
 
3. TNC development 
 
The TNC cells, which give rise to elements of the sympathoadrenal lineage take 
the dorsoventral migration route, passing mainly through the anterior parts of the 
somites [36]. During their migration they are exposed to signals from the somites, 
the ventral neural tube and the notochord. They aggregate in the vicinity of the 
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dorsal aorta, where they form the so-called primary sympathetic ganglia and 
undergo neuronal and catecholaminergic differentiation 
 
TNC cells encounter a variety of transient structures, which undergo their own 
remodeling, as the cells emigrate from the dorsal neural tube and migrate into 
the periphery. They do so in three stages – early, mid and late stage – and these 
are controlled by a tightly regulated expression of specific molecular factors [37, 
38]. During the early stage of migration, NC cells emigrate ventrally between the 
neural tube and the somites along intersomitic vessels. At this stage, the NC 
cells express type2 neuropilin (Nrp2), while the presumptive dermomyotome 
within the somites express type3A semaphorin (Sema3A). As this occurs, the 
epithelial somites will dissociate to give rise to dermomyotome and the eventual 
sclerotome. This dissociation is believed to be caused by an upregulation of Nrp1 
within the trunk NC [37, 39].  
 
In the middle phase of migration, a subset of TNC cells migrate dorsolaterally or 
ventrolaterally (in mouse and chick, respectively) into the rostral sclerotome, 
while the remaining cells aggregate at the dorsal aortae. Low levels of Sema3A 
and Sema3F expression in the caudal sclerotome, but mainly Sema3A in the 
dermomyotome, are important in repelling the NC cells at this stage from the 
intersomitic space [40]. This leads to restriction of the NC cells to only the rostral 
sclerotome [41]. 
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Finally, during late-stage migration, the subset of TNC cells that invaded the 
somites aggregate to form the segmented dorsal root ganglia. This is due to 
downregulation of Sema3F in the caudal sclerotome and a corresponding 
upregulation of Sema3A [42]. Alternatively, the subset of TNC cells that goes on 
to colonize the dorsal aortae is induced along the sympathoadrenal lineage, and 
begins to aggregate into the primary sympathetic ganglia. 
 
3.1. Sympathetic nervous development 
There are two major schools of thought regarding TNC induction and 
specification into the sympathoadrenal cell lineage. One proposal is that both the 
sympathetic precursors, which give rise to neurons in the sympathetic ganglia, 
and the chromaffin cells, which give rise to the adrenal lineage, originate from a 
the same homogenous population of cells. However, more recently, it has been 
proposed that these two lineages may originate from two different pools of 
precursors which determine which subpopulations of NC cells colonize the dorsal 
aorta and which ones migrate onwards into the adrenal anlage [43, 44]. 
 
A major player in TNC induction is the BMP family of proteins [43]. It is believed 
that as NC cells migrate pass the dorsal aorta, they are inducted by BMP 
signaling to develop into sympathoadrenal precursors. In addition to BMP 
signaling, expression of other factors such as Gata3, Phox2b and Mash1/2 have 
been shown to be important for proper specification of the NC along both the 
sympathetic and adrenal lineages [45]. However, in both cases, induction is 
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believed to occur both along the neural tube and migratory pathway, and finally 
at the site of colonization at the dorsal aortae. Despite the fact that adrenergic 
markers such as tyrosine hydroxylase (Th) are not seen to be expressed until the 
TNC colonize the dorsal aortae, the tissues lining the migratory pathway clearly 
play a role in inducing TNC along the sympathoadrenal lineage [46].  
 
It is now believed that the notochord, ventral neural tube and somitic mesoderm 
are all important in inducing adrenergic differentiation in TNC cells. This was 
demonstrated by a number of explant experiments done in chick embryos [47] 
and ablation experiments involving the removal of both notochord and ventral 
tube, which inhibited differentiation of trunk NC cells into sympathetic ganglia 
[48]. According to other similar experiments, which also involved removal of 
notochord and neural tube, induction at the site of colonization of the dorsal 
aortae is still dependent on proper expression of earlier factors along the 
migratory pathway [46]. 
 
3.2. Sympathetic ganglia colonization 
The formation and colonization of sympathetic ganglia occurs in three major 
stages – migration, desegmentation and resegmentation. Initially, migratory trunk 
NC cells migrate segmentally from the dorsal somite towards the dorsal aorta. 
They are guided by a complementary series of receptor expression and their 
corresponding ligands. Properly specified TNC cells will intrinsically express 
ErbB2, ErbB3 and CXCR4 receptors [37]. This is important in providing guidance 
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cues to the crest cells as they migrate through the dorsal somite, which 
expresses receptor-specific ligands such as neuregulin (ligand for ErbB2, ErbB3 
receptors) and CXCL12 (ligand for CXCR4 receptor). In addition to these 
guidance cues, the dermomyotome and notochord also express Sema3A which 
is important in repelling TNC cells via signaling with Nrp1, which is expressed in 
the crest [40]. As a result of a combination of repulsion and attraction cues, the 
trunk NC cells are able to migrate through the dorsal somite toward the dorsal 
aorta. 
 
The second and third stages occur at the site of the dorsal aorta, and involve the 
segmental state of the migratory TNC cells. As they colonize the aorta, they 
become desegmented, allowing them to diffuse along the outer wall. At this 
stage, segmental populations of trunk crest are indistinguishable from each other 
based solely on their location. However, once the crest cells are evenly 
dispersed along the aorta, they undergo resegmentation, allowing the formation 
of the metameric sympathetic ganglia [37].  
 
3.3. Adrenal formation  
In the mouse, adrenal development begins at E11.5, which is at least two days 
post-delamination of TNC from the neuroepithelium. The adrenal gland is formed 
from an adrenal primordium located along the urinogenital ridge of the 
developing embryo. TNC cells are important in forming the medulla of the 
adrenals, which is surrounded by a multilayered mesoderm-derived cortex. The 
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cortex is formed by budding from the coelomic epithelium between the 
mesogastrium and the urogenital fold. Alternatively, the medulla is composed of 
chromaffin cells and ganglion cells, which produce and circulate catecholamines 
respectively. 
 
During development, TNC cells that have been fated to differentiate along the 
sympathoadrenal lineage migrate from the dorsal neural tube to the adrenal 
primordium. Certain transcription factors, such as those belonging to group E of 
the Sox protein family (SoxE), including Sox8, Sox9 and Sox10, may be 
important during the process of adrenal gland formation [44]. During migration 
from the neural tube, as described earlier, TNC pass by the anterior region of the 
somites and a subset of these cells will colonize the sympathetic ganglia located 
adjacent to the dorsal aorta. In the mouse, by E12.5, the trunk crest has already 
colonized the adrenal medulla, and formation of both the medulla and cortex is 
completed by E15 [49].  
 
Expression of Sox8 and Sox9 begins before the TNC cells have delaminated 
from the neural tube, and it is believed to be important in early specification [50, 
51]. However as they undergo delamination from the NT, Sox9 is downregulated 
in favor of induction of Sox10, which maintains expression throughout migration 
of the TNC and their eventual colonization of the adrenal medulla, where it is co-
expressed with Sox8 [52, 53]. Recent studies suggest that Sox10 is very 
important for normal adrenal development [44]. Sox10-deficient mice did not form 
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an adrenal medulla, due to lack of TNC cells colonizing the adrenal anlage. 
These findings is consistent with earlier studies [54] showing that dominant-
negative expression of Sox10 in mice resulted in no adrenal formation. 
Alternatively, despite expression of Sox8 within the medulla, Sox8-deficient mice 
did not have significant defects in adrenal formation, except when placed on a 
Sox10 hypomorphic background [44].  
 
In addition to regulating TNC cell survival, Sox10 may also be important in their 
differentiation, as the reduced number cells in mutant mice around the dorsal 
aorta lacked proper specification and eventually underwent apoptosis. These 
cells lacked proper expression of Phox2b and Mash1, indicative of a previously 
suggested role of Sox10 in induction of molecular factors important in the 
establishing and maintaining the sympathoadrenal lineage [55, 56]. 
 
4.  In utero lethality due to defects in cardiac and trunk neural crests 
 
4.1. In utero lethality associated with CNC  
Myocardial defects associated with CNC have been an interesting conundrum in 
the field of cardiovascular development. This is primarily because CNC cells are 
not believed to directly contribute to the myocardium of the developing heart. 
However, quite a few animal models of NC have been found to have problems 
with myocardial function. One of the earliest models was studied in chick 
embryos, in which the NC had been surgically ablated [14]. These embryos, in 
 15
addition to classic NC-related defects, also displayed signs of myocardial 
dysfunction and died before birth [57]. Specifically, they had depressed calcium 
transients, problems with excitation-contraction coupling and low ejection 
fraction.   
 
In mouse, embryos homozygous for the Splotch (Sp2H) mutation in the Pax3 
gene display similar conotruncal anomalies associated with cardiac NC 
malformations [58]. However, these embryos also die by mid-gestation due to 
apparent poor cardiac output [59, 60], and exhibit similar myocardial-related 
defects to the chick-ablation model. In Splotch embryos, there is a failure of CNC 
to populate the arches and OFT septum in proper numbers [19]. However, unlike 
the ablation model, there are still some CNC-derived cells that make it into the 
aorticopulmonary septum. 
 
There has been some suggestion that CNC cells are required to mediate growth 
factor signaling between the OFT myocardium and the ventral pharyngeal 
endoderm. Specifically, studies have reported FGF signaling to be important for 
normal elongation and remodeling [61]. Continuous expression of FGF2 and 
FGF8 in the ventral pharyngeal endoderm can be detected as cardiac NC cells 
are still migrating and before they reach the OFT myocardium. In chick embryos, 
FGF upregulation occurs prior to the arrival of cardiac NC cells in the OFT. 
Conversely, haploinsufficiency of FGF8 in embryonic mice also results in OFT 
alignment defects including PTA [62, 63] due partly to an increase in CNC cell 
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apoptosis. This suggests regulated FGF8 expression in the pharyngeal 
endoderm is important in both OFT development and perhaps myocardial 
stability. Interestingly, reduction of FGF signaling in chick embryos that have 
undergone CNC ablation is sufficient to normalize abnormal calcium transients 
reported earlier [61]. Furthermore, backtransplantation of CNC cells into NC-
ablated chick embryos is able to normalize calcium transients and partially 
rescue the myocardial phenotype [5, 61]. To our knowledge, FGF signaling has 
not been comprehensively studied in the Splotch mouse model. However, it is 
believed that CNC cells are important in mediating signaling to the myocardium 
of the developing heart, which must be required for normal cardiac function and 
output. 
 
4.2. In utero lethality associated with TNC 
Similarly, there are a number of animal models of TNC that have been shown to 
be associated with myocardial defects. Perhaps, the most significant model 
reported is that of the tyrosine hydroxylase (Th) knockout mice. Tyrosine 
hydroxylase is an enzyme important in the catalytic conversion of L-tyrosine to 
DOPA (a catecholamine intermediate) in the catecholamine synthesis pathway 
(Figure 3) that leads to production of norepinephrine and epinephrine 
(adrenaline). Th null mice are embryonic lethal by E11-15 [64, 65]. Although they 
appear grossly normal, the embryos displayed congestion of blood in the liver 
and atrial wall thinning. Furthermore, they had slight bradycardia and 
disorganization of ventricular cardiomyocytes. Since TNC cells do not contribute 
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directly to the cardiomyocyte cell population, the observed cardiac defects 
proved to be an even more significant result.  The authors postulated that the 
observed lethality was due to a catecholamine deficiency caused by failure of 
TNC to properly give rise to developing sympathetic neurons, adrenal chromaffin 
cells and enteric neurons. They confirmed this by feeding pregnant dams with L-
DOPA and were able to rescue at least 50% of mutant embryos to term, even 
though the rescued mutants were severely runted and died within a few weeks 
after birth. They also observed similar results in dopamine beta-hydroxylase 
(Dbh) knockout mice. Dbh is also involved in later stages of catecholamine 
synthesis, by catalyzing conversion of dopamine to norepinephrine (Figure 3).  
However, since the observed lethality occurred before cathecolaminergic 
neurotransmission is completely established, the study postulated that 
catecholamines probably act in a paracrine manner at these early stages [64-66]. 
 
In addition to the Th knockout mice, the Gata3 knockout mouse model has been 
quite informative in this regard. These mice are also embryonic lethal by mid-
gestation, and display deficiencies in Th, Dbh and noradrenaline [67].  The 
mutants were also rescued to birth by administration of DOPS (a synthetic 
catecholamine intermediate) to the pregnant dams. Similar to the Th knockouts, 
these mutants were also reported to have loosely organized cardiomyocyte 
structure, as well as blood congestion in the heart, and had poorly developed 
neural crest-derived structures. However, the authors were unable to 
conclusively link the exact role of Gata3 in Th/Dbh activity and subsequent heart 
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failure in these mutants. Based on subsequent in vitro studies, it is now believed 
that Gata3 can directly bind to the Th promoter and regulate its transcription [68]. 
 
More recent studies, have suggested that while expression of Th and Gata3 
within the TNC may be required for normal sympathetic neuron development, 
expression of much earlier molecular factors are important in determining their 
noradrenergic identity. Hand2 has been shown to be required for early 
specification of the noradrenergic cell lineage. Conditional deletion of Hand2 
within the neural crest leads to embryonic lethality by mid-gestation and severe 
cardiovascular defects [69]. These mutants displayed reduced specific reduction 
in the expression of Th and Dbh. However, it concluded that Hand2 regulation of 
both Th and Dbh expression is independent of Gata2/3, Phox2a/b and Mash1, 
which are markers of sympathetic neuronal differentiation [70-72], but are all 
normally expressed in these mutants.  
 
5. Pax3: an important transcription factor 
 
Pax3 (paired box 3) is a transcription factor belonging to the Pax family of 
proteins. They get their name from the fact that all members contain a paired box 
domain and a paired-type homeodomain involved in DNA binding and regulation 
of downstream targets. A number of different syndromes in humans are 
implicated by mutations in Pax3. Two such syndromes are Waardenburg 
syndrome (WS) and DiGeorge syndrome (DGS).  
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 Patients with WS have a range of features including sensorineural deafness, 
pigmentation anomalies (white forelock, forehead), and abnormalities in skeletal 
and neurological development [73, 74]. WS has a prevalence of 1 in 15000 within 
the general population, and it has been observed to be as high as 1 in 30 
students in schools for the deaf. Although the Pax3 gene is located on human 
chromosome 2q35 [75, 76], it has also been implicated in DGS. Patients with 
DGS display the CATCH 22 phenotype (cardiac defects, abnormal facies, thymic 
hypoplasia, cleft palate, hypocalcaemia; associated with microdeletion on 
chromosome 22q11). Cardiac defects include interrupted aortic arch, PTA, and 
other arch artery defects. There are a considerably high proportion of patients 
with these cardiac defects, who also carry the microdeletion [77]. The general 
prevalence is about 1 in 6000 births, which makes it a fairly common syndrome. 
The microdeletion varies from patient to patient, but can encompass as much as 
a 3-million base-pair deletion, and as many as 30 genes have currently been 
identified. Pax3 is believed to have a cooperative or interactive role with some of 
these genes, and thus, patients with mutations in Pax3 also display similar 
features of DGS. 
 
5.1. Role as both an effector and regulator 
Pax3 expression diminishes in a rostrocaudal direction along the axis of the 
neural tube and as NC cells begin to emigrate. Based on avian studies, this may 
be modulated by BMP4, which has been shown to be capable of maintaining 
 20
ectopic Pax3 expression at late post-delamination stages in the embryo [78]. 
Several models have been designed to further study the effects of BMP signaling 
on cardiac development. BMP2 and BMP4 have been shown to be important for 
neural crest induction, migration and differentiation. Mice deficient for Bmpr1a 
receptor within the NC display OFT and arch artery remodeling defects [79]. 
These mice also die mid-gestation due to apparent heart failure.  
 
Another molecular factor that has recently been shown to be a direct downstream 
effector of Pax3 within the NT is Msx2 [80]. Msx2 is a homeobox gene and is 
also involved in regulation of BMP signaling. Mice deficient for Msx2 are viable, 
but have cranial defects including problems with skull ossification, calvarial 
bones, and teeth formation [81]. Interestingly, Msx2 has been shown to be 
upregulated in Splotch mutants, and a loss of function Msx2 mutation in the Pax3 
homozygote background rescues the previously described cardiac defects [80].  
 
5.2. Role in NC and heart development  
As a transcription factor, Pax3 is involved in numerous developmental processes. 
In mice, Pax3 expression begins by E8 [82]. It is expressed in the dorsal neural 
tube, including but not restricted to NC progenitors, and somites (musculature) of 
the developing embryo. It is involved in formation of myogenic precursors [83], 
peripheral nervous system and melanocyte differentiation [84], and most 
importantly, early CNC cell formation and delamination from the neural tube. Its 
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expression diminishes as the CNC cells colonize the arches and is completely 
gone in the OFT [85].  
 
Splotch homozygote embryos display neural tube and NC-related defects, 
including PTA and accompanied interventricular septal defect [15, 58, 60, 85], 
but surprisingly die by embryonic day 14. However, it is unclear why Pax3 mutant 
embryos fail to survive past the mid-gestation. As mentioned earlier, embryonic 
lethality had previously been postulated to be due to poor cardiac function and 
output secondary to myocardial defects [15, 59]. Transgenic rescue studies using 
a well-defined 1.6kb Pax3-promoter [86] showed restricted re-expression of Pax3 
in the NT and NC in a Pax3 null background was sufficient to rescue the cardiac 
phenotype. Not only was PTA rescued, but these mice also survived to birth. 
However, they still had musculature defects and eventually died due to 
respiratory failure shortly after birth. From these studies, it is now clear that 
restricted Pax3 expression within the NT and perhaps the NC specifically, may 
be important in maintaining normal cardiac function and output in the developing 
mouse embryo. However, the underlying cause of embryonic lethality in Pax3 
mutants is still unknown. 
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6. Hypothesis 
 
The observed mid-gestation lethality in Pax3 mutant embryos led me to examine 
the underlying cause of poor cardiac function and embryonic death. This was 
particularly because PTA/VSD (the major heart defect of Pax3 mutants) is not 
sufficient to cause embryonic death, nor is Pax3 protein known to be expressed 
in the heart. Therefore, I proposed to compare the specific consequences of 
Pax3-deficient migratory NC cells on AAA and OFT remodeling and determine 
the secondary effects this may have on embryonic cardiac output. To do this, I 
used two mouse models of NC-deficiency. The first mouse model was a Pax3-
deficient model, which was lethal by E14, and had appreciably reduced numbers 
of migratory NC cells. The second mouse model was a NC-ablated model, which 
was surprisingly viable and survived to birth, despite an apparent lack of 
migratory NC cells. I hypothesize that having Pax3 mutant CNC, albeit in fewer 
numbers (as is the case in Pax3 mutants), is more detrimental than complete 
absence of wildtype CNC (as is the case in the NC-ablated model). 
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Figure 1: Cardiac and trunk NC subpopulations and their derivatives. 
Adapted from [5]. 
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 Figure 2: Schematic representation of the sequential changes that occur 
during remodeling of aortic arch arteries. Adapted from [2, 15]. 
 
 
 
Figure 3: Catecholamine synthesis. Adapted from image obtained from 
http://themedicalbiochemistrypage.org/nerves.html. 
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Chapter II: Pax3 is required during very early neural crest formation and 
specification for normal cardiogenesis 
 
1. Abstract 
 
Pax3 is a transcription factor that is important in regulating several 
developmental processes during embryogenesis. Its restricted expression to the 
dorsal NT, premigratory NC and somitic mesoderm has allowed for several loss-
of-function studies to be performed. However, to address the NC-specific 
requirement of Pax3, a floxed Pax3 allele was generated. This allowed for both 
systemic and conditional knockout studies to be carried out via selective Cre-
mediated recombination. NC lineage mapping studies revealed that systemic 
Pax3 mutants phenocopy the previously published Splotch (Sp2H) homozygous 
phenotypes, including AAA remodeling defects, PTA/VSD, and mid-gestation 
lethality by embryonic day 14. This abnormal remodeling is due to insufficient 
CNC colonizing the AAA’s and OFT region of the developing heart. However, 
NC-specific deletion of Pax3 using both Wnt1Cre and Ap2aCre failed to fully 
recapitulate these defects, and these embryos survived to birth. In order to 
assess the tissue-specific contribution of CNC to heart development, genetic 
ablation of NC using a Wnt1Cre-activated ROSA26-diphtheria toxin fragment-A 
(Wnt1Cre/DTA) cell-killing system was performed. Ablation of Wnt1Cre-
expressing NC generated fully penetrant PTA/VSD defects similar to the Pax3 
systemic mutants. However, astonishingly, ablated mutants survive to birth (well 
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past the E14.0 lethality observed in systemic Pax3 mutants) similar to the 
conditional Pax3 mutants. Taken together, these data suggest that Pax3 is 
important in early neural crest specification and formation prior to the expression 
of both Wnt1Cre and Ap2aCre. 
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2. Introduction 
 
The NC is a multipotent, undifferentiated population of cells, which are derived 
from the region of the neuroepithelium that borders the surface ectoderm of the 
NT [1].  They contribute to the development of several different tissue and organ 
types in the mammalian embryo including the PNS (neurons, sensory ganglia, 
sympathetic/parasympathetic ganglia/plexus and Schwann cells); endocrine 
derivatives (adrenal medulla, calcitonin-secreting and carotid body cells); 
melanocytes, facial cartilage/bone/teeth papillae and elements of the great 
arteries/OFT.  They do so in four steps, which include proper formation and 
specification, delamination from the neural folds via epithelial-to-mesenchymal 
transformation, migration to their target tissue and, finally, differentiation and 
colonization [4, 6]. Defects in one or more of these steps have been implicated in 
several CHDs [5, 35]. This is because a subpopulation of NC, known as the CNC 
has been shown to be important in contributing to heart morphogenesis and 
remodeling.  
 
Based on lineage mapping studies done in mouse, it has now been conclusively 
shown that the CNC is derived from the region corresponding between 
rhombomeres 5 - 8 [2, 4, 25, 26]. In addition to providing all of the 
parasympathetic innervation of the developing mammalian heart [14], migratory 
CNC also contribute to the smooth muscle cells that surround the aortic arches 
and the mesenchymal cells that colonize the OFT. They migrate through the 
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pharyngeal arches 3, 4 and 6 [17], on their way to colonizing the OFT where they 
coalesce into ridges of connective tissue [6].  Importantly, the CNC are not 
required for the initial formation of the AAA’s, but are required for their final 
patterning [18].  The CNC cells migrate into each arch as it successively forms 
where they surround the endothelial cells that form the emerging AAA’s.  Thus, 
improper specification or migration of CNC can lead to abnormal 
regression/persistence of AAA’s [5], which results in OFT defects such as 
PTA/VSD. 
 
Pax3 is a transcription factor that is involved in numerous developmental 
processes including cardiac development.  In mice, Pax3 expression begins ~ E8 
[82]. It is expressed in the dorsal NT (including but not restricted to NC 
progenitors) and somites (musculature) of the developing embryo. It is involved 
in early NC migration and formation/migration of myogenic precursors [83], PNS, 
and involved in melanocyte differentiation [84]. Previously published Pax3 
homozygote Splotch mutant embryos display NT (spina bifida, exencephaly) and 
NC-related defects.  They also display absent limb and hypaxial muscles.  In the 
heart, these mice exhibit 100% PTA/VSD and AAA remodeling defects [58, 85] 
and die by E14.0. Previous transgenic rescue studies using a 1.6kb Pax3-
promoter (Pax31.6kb) showed re-expression of Pax3 in the NT/NC alone in a Pax3 
null background was sufficient to rescue the heart phenotype [86]. Not only was 
PTA rescued, but these mice also survived to birth. However, they still had 
musculature defects and eventually died due to respiratory failure. Thus, it is 
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clear that Pax3 expression in NT/NC is important in maintaining normal heart 
function in the developing mouse embryo. However, since Pax3 is not expressed 
in the heart, its role in heart development is most likely linked to its role in NC 
development.  
 
To address this possibility, a novel Pax3 allele was utilized [87], which allowed 
for the generation of both homozygote systemic Pax3 delta-exon5 (Pax3d5/d5) 
knockout and conditional Pax3 (Pax3f/d5/Wnt1Cre and Pax3f/d5/Ap2aCre) 
knockout mice. These mouse lines were then compared to the Wnt1Cre/DTA 
mouse, which allowed for permanent, genetic ablation of the Wnt1Cre-
expressing NC lineage in the developing embryo. The results of this project 
provide more insight into understanding the role that Pax3 plays intrinsically 
within the CNC in both AAA and OFT remodeling. Specifically, these results 
suggest that Pax3 plays an early role in NC formation and specification, but is not 
required for the secondary stages of NC development involving its migration and 
colonization. 
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3. Materials and Methods 
 
3.1. Mouse colonies, breeding, genotyping and PCR 
The Pax3 floxed conditional allele was generated as previously described [87, 
88]. Exon 5 of the Pax3 gene, which encodes the Pax3 homeodomain, was 
flanked by 5’ and 3’ loxP sites. This allowed for Cre-mediated removal of the 
floxed Pax3 homeodomain. To selectively remove the floxed allele in the 
germline, adult male heterozygous floxed Pax3 (Pax3f/+) mice were crossed to 
female C57Bl6/129 Tie2Cre-positive females to generate heterozygous delta 
exon 5 Pax3 (Pax3d5/+) adult mice. The resultant Pax3d5/+ males were crossed to 
wildtype C57Bl6/129 females to remove the Tie2Cre transgene. Pax3d5/+ 
(Tie2Cre-negative) mice were then intercrossed to generate Pax3d5/d5 mutant 
embryos. Furthermore, adult Pax3d5/+ (Tie2Cre-negative) were crossed to adult 
homozygous Pax3f/f mice to generate adult heterozygous Pax3f/d5. PCR 
screening strategy was used as previously described [88]. The Pax3f/d5 and 
Pax3d5/+ mice were then crossed into both the Wnt1Cre mouse [4] and Ap2aCre 
mouse (generous gift from Anne Moon, University of Utah) to carry out 
conditional knockout and lineage mapping studies (Scheme 1). The R26R-lacZ 
reporter mice were obtained from Jackson Laboratories (JaxLab stock #003474) 
and the ROSA26-eGFP-DTA (R26R-DTA) mice were generously gifted by A. 
Copp (University College London, England). The R26R-DTA was made by 
introducing an eGFP-DTA (enhanced green fluorescent protein-diphtheria toxin 
fragment A) cassette into the ubiquitous ROSA26 reporter locus [89].  As a 
 31
result, R26R-DTA mice express eGFP ubiquitously, but diphtheria toxin A-chain 
(DTA) is switched on only when Cre is present to remove the floxed stop codon 
sequence in front of DTA-encoding sequence (Scheme 2). To generate the 
Wnt1Cre/DTA ablated mutant embryos, Wnt1Cre mice were crossed into the 
R26R-DTA mouse line to produce progeny that were both Wnt1Cre-positive and 
R26R-DTA positive. All mouse colonies for this study were maintained on a 
mixed C57Bl6/129 genetic background. Mice were housed and handled in 
accordance with Indiana University Institutional Animal Care and Use Committee 
guidelines. For timed pregnancies, the day of observed vaginal plug was 
designated embryonic day 0.5 (E0.5). 
 
3.2. Histological, in situ hybridization and immunohistochemistry analyses 
Embryos were fixed in 4% PFA overnight at 4°C and processed for paraffin 
histology as previously described [90]. Immunohistochemistry was carried out 
using ABC kit (Vectastain) with DAB and hydrogen peroxide as chromogens. The 
endogenous peroxidase was quenched via incubation in 0.3% hydrogen peroxide 
in methanol for 30min. For detection of Pax3, sections were boiled in antigen 
retrieval buffer (Dako) for 2min and then cooled to room temperature prior to 
blocking. Melanin intensification was performed by addition of exogenous DOPA 
(1mg/ml in PBS) for 10mins. Dilutions of primary antibody were 1:200 for goat 
anti-Pax3 antibody (Santa Cruz sc-7748) and 1:1000 for secondary anti-goat 
antibody. Incubation in primary antibody was carried out at 4°C overnight, and 
incubation in secondary antibody at room temperature for 30 minutes. 
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Radioactive in situ hybridization for Wnt1, Pax3, and Sox10 expression was 
performed as previously described [91]. Both sense and antisense 35S-UTP-
labeled probes were used as negative controls and experimental samples 
respectively. Analyses were performed on serial sections within at least three 
independent embryos of each genotype. To quantify expression differences, 
silver grains were counted per square area on serial sections. 
 
3.3. Wholemount X-gal (lacZ) staining 
Whole embryos were fixed in 4% PFA immediately after dissection for 2h. They 
were then washed 10min in PBS and subsequently washed 2x in β-gal buffer 
(0.058 M Na2HPO4, 0.042 M NaH2PO4, 0.001M MgCl2, 0.01% NP40), 5mins 
each. An additional wash was done overnight at 4°C, then embryos were 
changed into X-gal substrate (0.1% X-gal, 0.005M K3Fe(CN)6, 0.005M 
K4Fe(CN)6, 0.001M EGTA), and incubated at 37°C in the dark. Embryos were 
then fixed in 4% PFA after successful X-gal staining was completed.  
 
3.4. Immunoblot and reagents 
Immunoblots were performed using mouse monoclonal anti-Pax3 and anti-Pax7 
antibodies (both obtained from Hybridoma Bank, University of Iowa); mouse 
monoclonal anti-β-tubulin antibody (Roche); and HRP-conjugated goat anti-
mouse IgG (Jackson Laboratories). Both the anti-Pax3 (1:1000) and anti-Pax7 
(1:1000) antibodies were incubated overnight at 4°C. Anti-β-actin (1:10000) and 
goat anti-mouse (1:5000) antibodies were incubated for 1h at room temperature. 
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Antibodies were detected using the enhanced chemiluminescence (ECL) plus 
detection system (Amersham). To maintain equal loading between blots, 
membranes were stripped after each blot using stripping buffer (Thermo 
Scientific) at 55°C for 30min, and then subsequently oscillated for additional 
30min, before being blocked in 5% milk dissolved in 0.1% PBS-Tween20 and 
reprobed. Densitometry of immunoreactive bands was performed using Image J 
1.37v (NIH). 
 
3.5. Cardiac ink injection analysis 
For gross examination of the cardiovascular system, embryos were injected with 
Pelican India ink (diluted 50% in PBS) into the left ventricle of the heart, 
accessed through the pericardium or into the umbilical vessels. Glass capillary 
tubes (1-2mm internal diameter) were drawn over a Bunsen flame and then 
broken diagonally to give long, fine, sharp glass needles. Needles were loaded 
with ink and injected using a standard mouth pipette. Prior to injection, maternal-
embryonic connections were maintained and the embryos kept at 37°C to 
maintain continuous heartbeat. Immediately following injection, embryos were 
fixed in 4% PFA at 4°C overnight, processed through a series of methanol/PBS 
dilutions (10%, 20%, 30%, 50%) to 100% methanol, and cleared for several 
hours in 2:1 volume of benzyl benzoate and benzyl alcohol respectively. 
Genotypes of all embryos were confirmed by DNA extraction from the yolk sac, 
and successive PCR analysis. 
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4. Results 
 
4.1. Pax3d5/d5 systemic knockout recapitulates Sp2H mutant embryos   
Mice homozygous for Pax3 conditional allele (Pax3f/f) were generated, with 
exon5 flanked by loxP-sites.  Crossing male Pax3f/+ with Tie2Cre transgenic 
females generated germline (via oocyte-expressing Cre activity) heterozygous 
deletion of exon5 (Pax3d5/+).  Although Tie2Cre is normally expressed in the 
endothelium, it is also transiently expressed in adult ovary oocytes [92]. Thus, by 
crossing a Tie2Cre-positive female with a Pax3f/+ male, generation of 
heterozygous Pax3d5/+ systemic knockouts was possible. Intercrossing of 
Pax3d5/+ heterozygotes generated Pax3d5/d5 mutants. Deletion of exon5 creates a 
premature stop codon and loss of Pax3 homeodomain and its downstream 
sequence.  Western analysis using antibody that recognizes the C-terminus of 
Pax3 (missing in d5 mutant protein) confirmed that wildtype Pax3 protein is 
absent in the homozygous mutant, but levels of the closely related Pax7 are 
unaffected. All protein samples were normalized relative to Actin protein (Figure 
4A).  Pax3d5 allele recapitulates all aspects of Splotch (Pax3Sp2H) allele (4B-I) 
including pigmentation defects in heterozygotes (Pax3d5/+), 100% penetrant 
PTA/VSD, NT closure defects and mid-gestational lethality by embryonic day 14 
(E14.0) in homozygote mutants (Pax3d5/d5). Furthermore, analysis of Pax3d5/+ and 
Pax3Sp2H/+ compound mutants (i.e. Pax3d5/Sp2H) demonstrated that the Pax3d5 
allele is genetically identical to the Pax3Sp2H allele (data not shown).  
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4.2. Pax3d5/d5 systemic knockout displays specific regression of left 6th AAA 
The pathogenesis of the OFT remodeling defect in Pax3 mutants is due to the 
failure of the left 6th AAA to persist, which normally gives rise to the pulmonary 
trunk. Thus, in its absence, there is formation of a single OFT from the left 4th 
AAA (normally gives rise to aorta), leading to PTA/VSD. At E10.5, there are no 
observable differences in AAA remodeling between Pax3 mutants and control 
littermates (Figure 5A-C). However, by E11.5 the left 6th AAA undergoes 
regression in mutant embryos when compared to controls (5D, E). Interestingly, 
there are no observable differences in left 3rd, 4th AAA remodeling between the 
two genotypes. Also, other AAA’s undergo normal regression/persistence, 
suggesting a Pax3-specific role in left 6th AAA remodeling. Due to the regression 
of the left 6th AAA, OFT septation is abnormal by E13.5 in Pax3 mutants. Control 
embryo hearts at E13.5 undergo proper septation of the OFT into the pulmonary 
artery and aorta (5F). However, Pax3 mutant embryo hearts develop a range of 
PTA defects including Types I and III (5G, H), which respectively involve two 
incompletely separated vessels and a single vessel exiting the heart. 
 
4.3. Migratory NC in Pax3d5/d5 mutants is appreciably reduced 
NC lineage mapping studies with Wnt1Cre to permanently label NC-derived cells 
via R26R-lacZ reporter were performed. This allowed for fate-mapping studies to 
be done in NC cells from ~E8.5 onwards, when Wnt1Cre expression begins in 
the CNC region. Differences in lacZ patterns as early as E9.0 (Figure 6A, B) in 
mutants were observed.  In Pax3d5/d5 mutants, lacZ-positive cells appeared to 
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accumulate along the axis of the NT, which led to an overall delay in lateral 
emigration of NC. As a result, in addition to differences in overall number, a slight 
temporal delay in delamination of the NCC from the NT was observed in mutants 
at the E9 stage. This led to a delay in formation of NC-derived structures at this 
stage, including 1st and 2nd branchial arches, which were appreciably regressed 
in mutants (6B). By E9.5, NC cells appear to be migrating properly in both 
mutants and controls. However, there is a significant reduction in the number of 
NC cells that begin to colonize the 3rd/4th/6th pharyngeal aortic arches. The 
reduction in migratory CNC was determined to be Pax3-dose dependent, as 
slightly fewer lacZ-positive cells were observed in Pax3d5/+ heterozygote embryos 
when compared to wildtype littermates. However, there was an even more 
drastic reduction in migratory CNC observed in Pax3d5/d5 mutants even compared 
to heterozygote Pax3d5/+ embryos (6C). Histological examination of older lacZ-
stained embryos also revealed that the number of NC colonizing AAA’s that 
eventually invade the OFT region is reduced in mutants (6D, E). The 
aorticopulmonary and OFT cushions in Pax3d5/+ embryos are slightly less 
populated with NC cells when compared to wildtype. However, this slight 
reduction is not sufficient to affect normal OFT remodeling as Pax3 heterozygote 
(Pax3d5/+) embryo hearts undergo normal septation (data not shown). By E13.5, 
NC cells have completely colonized the distal region of the OFT as can be seen 
by the observed invasion of two streams of lacZ-positive cells. However, despite 
their ability to colonize the mutant OFT, they do so in fewer numbers (6F, H).  
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The Wnt1Cre lineage mapping studies was complemented with an additional NC 
reporter – AP2aCre – which was used to determine the effect of Pax3 deletion in 
a slightly earlier population of NC (as AP2aCre is expressed earlier by ~E8 in 
CNC region). Based on NC lineage mapping studies with Ap2aCre, both 
derivatives of the NC (known region of Pax3 expression) and ectoderm (known 
region of no Pax3 expression) were able to be permanently labeled and fate-
mapped in both Pax3 wildtype and mutant backgrounds. Results from this fate-
map study correlate with that of Wnt1Cre, and demonstrate that there is a 
marked reduction in overall numbers of migratory NC (Figure 7A, B). 
Furthermore, migratory CNC that colonize the 4th AAA is appreciably reduced 
(asterisks in 7E, F) and virtually no lacZ-positive cells within the 6th AAA of Pax3 
mutants were observed when compared to their littermate controls (asterisk in 
7G). In addition, a progressive loss of migratory CNC was observed in Pax3 
mutants from the 3rd to the 4th and finally the 6th AAA.  
 
4.4. Genetic ablation of CNC gives rise to OFT and AAA remodeling defects 
In order to assess the specific role of the Wnt1Cre-expressing population of NC 
in heart morphogenesis, the entire population of Wnt1Cre-expressing NC was 
ablated using the R26R-DTA system. Cre-mediated activation of DTA kills cells 
via apoptosis by interfering with the RNA translation machinery in each individual 
cell.  This system is highly cell autonomous and only cells that express the DTA 
are ablated without any effects on neighboring non-Cre expressing cells. Ablation 
of Wnt1Cre-expressing NC lineage led to fully penetrant PTA/VSD (Figure 8A-G). 
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Surprisingly, these embryos are viable and go on to live to birth (n=24/24 
mutants).  Wnt1Cre/DTA ablated mutants also displayed craniofacial defects (8A) 
including severe microcephaly (white arrow) consistent with significant NC 
contribution to the cranial region.  An absence of NC-derived structures such as 
thymus, dorsal root ganglia, and Schwann cells (not shown) was also observed.  
 
In order to visualize the DTA expressing cells and to determine how quickly the 
apoptosis of these cells was occurring, the Wnt1Cre/DTA mouse was crossed into 
the R26R-lacZ reporter mouse system to lineage map any potentially remaining 
Wnt1Cre-expressing migratory NC. Based on this analysis, it was determined that 
as early as E8.5 (when Wnt1Cre is expressed), the NC cells were almost 
completely gone in the NT as shown by an absence of lacZ-positive cells (Figure 
9A). Later stage analysis at E9.5 also confirmed successful ablation of Wnt1Cre-
expressing NC (9B, C). Therefore, this data suggests that the DTA is working very 
quickly-within ~6 hours of Cre expression and successive recombination.  
 
To determine the pathogenesis of the observed PTA/OFT defects, cardiac ink 
injections were performed in 3 separate Wnt1Cre/DTA mutant littermates at 
E11.5. All 3 embryos analyzed displayed severe defects in AAA remodeling. 
However, these defects were completely randomized and varied from each 
individual embryo. Embryo #1 had only 1 caudal AAA persisting on both the left 
and right side (9D, E). Embryo #2 displayed abnormal persistence of left 1st AAA 
but regression of left 6th AAA. In addition, it displayed abnormal regression of right 
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4th AAA (9F, G). Embryo #3 displayed abnormal persistent of left and right 1st and 
2nd AAA’s. In addition, it displayed abnormal regression of left 3rd AAA (9H, I).  
 
4.5. Wnt1Cre-mediated ablation fails to capture earlier wave of NC cells 
In order to determine if indeed the entire NC population was being ablated, 
marker analyses on ablated mutant embryos at E13.5 were performed by 
radioactive in situ hybridization. To do this, a series of well-established markers 
of premigratory NC (Wnt1), migratory NC (Sox10), and both premigratory and 
early migratory NC (Pax3) were used (Figure 10). It was determined that 
Wnt1Cre-mediated ablation was successful in ablating both Wnt1- and Pax3-
expressing population of premigratory and early migratory NC cells (10: top and 
middle panel). However, a few late-stage migratory Sox10-expressing cells were 
detected in ablated embryos (10: lower panel). This suggests that Wnt1Cre-
mediated ablation does not successfully kill the entire NC population, and 
suggests that there is an earlier wave of NC delaminating from the NT that does 
not express Wnt1Cre. However, this earlier wave of NC cells is still insufficient for 
proper AAA and OFT remodeling. 
 
4.6. Pax3f/d5/Wnt1Cre conditional mutants do not phenocopy Pax3d5/d5 OFT 
defects  
To determine the CNC-intrinsic role of Pax3, conditional knockout studies were 
performed as described earlier to ablate Pax3 in the Wnt1Cre-expressing NC cell 
lineage. Surprisingly, conditional mutants (Pax3f/d5/Wnt1Cre) were found to not 
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display defects in OFT/AAA remodeling as seen in Pax3d5/d5 systemic mutants 
and were viable till birth (based on analysis of >200 embryos, from E10.5 – 
E19.5). However, consistent with the rostrocaudal onset of Wnt1Cre-expression, 
56% of these mutants displayed exencephaly (n=28/50) but not spina bifida 
(Figure 10C, F).  
 
Wholemount embryo analysis of lacZ-positive cells did not reveal any defects in 
CNC migration or colonization of AAA or OFT regions (10A, D). However, some 
disorganization of dorsal root ganglia and NC-derived Schwann cells in mutant 
embryos was observed (10B, E). In addition, newborn conditional mutants 
displayed pigmentation defects due to anomalous differentiation of NC-derived 
melanocytes. This was determined based on the similar distribution of NC-
derived melanocytes in the basal epidermis of both conditional mutants and 
control pups (10 day old), but a significant reduction in melanin synthesis in 
mutants (10I, J). 
 
To confirm successful Wnt1Cre-mediated recombination of the Pax3f/d5 allele, in 
situ hybridization was performed at E10 using both an exon5-specific Pax3 
probe, which detects only wildtype Pax3 transcript. The exon5-specific probe did 
not detect signal in dorsal-most region of the NT corresponding to known 
Wnt1Cre-expression domain (10G, H). In addition, immunohistochemistry 
analysis was performed using anti-Pax3 antibody at E10 to determine 
presence/absence of Pax3 protein. The antibody failed to detect any Pax3 
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protein in the Wnt1Cre-expressing region of the NT of conditional mutants (arrow 
in 10J) when compared to control littermate (10I).  Together, these results 
confirmed successful deletion of exon5 within the Wnt1Cre-expressing domain of 
the NT. 
 
4.7. Pax3f/d5/AP2aCre conditional mutants display less severe OFT/AAA 
defects than Pax3d5/d5 systemic mutants  
Due to the absence of AAA/OFT remodeling defects in the Pax3f/d5/Wnt1Cre 
conditional mutants, an alternative conditional approach was used in an attempt 
to recapitulate the Pax3d5/d5 phenotype. Alternative conditional knockout studies 
were performed as described earlier to delete Pax3 in an earlier population of NC 
cells via AP2aCre-mediated recombination. AP2aCre expression can be seen as 
early as E8 (~0.5 day earlier than Wnt1Cre) within the neural folds and 
neuroepithelium (Figure 11A). Importantly, it marks CNC-derived cells that 
eventually colonize the OFT region (11B, C). As a result, this alternative 
conditional approach was done to determine if the lack of phenotype seen in 
Pax3f/d5/Wnt1Cre mutants was due to an inability of Wnt1Cre to successfully 
delete Pax3 early enough within the NC before they had undergone proper 
formation and specification. As anticipated, Pax3f/d5/AP2aCre mutants were 
observed to have some OFT/AAA defects, although not as severe as Pax3d5/d5 
mutants. Similar to Pax3f/d5/Wnt1Cre mutants, these conditional mutants were 
viable till birth and displayed exencephaly, but not spina bifida (Figure 11F).  
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Wholemount embryo analysis of lacZ-positive cells revealed decreased CNC 
migration and colonization of caudal AAA’s (3rd/4th/6th) and OFT region (11D-G). 
Histological analysis confirmed reduced distribution of CNC cells colonizing the 
AAA’s and invading the OFT (11H, I). However, ectodermal derivatives were 
unaffected, as Pax3 is not expressed in this region (arrows in 11H, I). In addition, 
conditional mutants displayed AAA/OFT remodeling defects including 
DORV/VSD (11J-M). However, fully penetrant PTA as seen in Pax3d5/d5 
mutants was not observed. 
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5. Discussion 
 
This project focused on the CNC-intrinsic role of Pax3 during OFT/AAA 
remodeling. In order to do this, a number of mouse models were utilized to 
elucidate the effect of ablation of Pax3 within the CNC and how that compared to 
a gross ablation of the CNC population itself.  
 
First, we compared Pax3d5/d5 systemic mutants to previously published Pax3sp2H 
mutants. Based on the NC lineage mapping and histological analyses done on 
Pax3d5/d5 mutants, it is clear that the Pax3d5 allele completely recapitulates the 
previously published Pax3sp2H allele [58, 85]. By comparing Pax3d5/d5 systemic 
mutants to Wnt1Cre/DTA ablated mutants, we were able to tease out the Pax3-
specific role in CNC during AAA remodeling. The fact that Pax3d5/d5 mutants only 
display specific regression in the left 6th AAA, despite the reduction in migratory 
CNC to caudal AAA (3rd/4th/6th) suggest a potential left 6th AAA-specific role 
encoded by Pax3. It may also be indicative of a 6th AAA over-sensitivity to loss of 
Pax3 when compared to the other caudal AAA’s (i.e., 3rd/4th). Surely, the 
rostrocaudal progressive loss of migratory CNC observed in Pax3d5/d5 mutant 
AAA’s (based on both Wnt1Cre and Ap2aCre lineage mapping data), which is 
most severe in the 6th AAA compared to 3rd/4th, lends credence to this theory. 
Although migratory NC’s are not important for the initial formation of AAA’s, they 
are required for their remodeling. This has been successfully demonstrated by 
surgical ablation studies done in chick embryos, which result in a wide variation 
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of AAA anomalies [14, 18]. Given the absence of migratory NC’s in 
Wnt1Cre/DTA mutants, we expected randomized AAA remodeling defects in the 
ablated model. However, the differences in severity of AAA remodeling between 
the ablated mutants and Pax3 mutants may be important in determining 
consequences of incorrectly programmed mutant Pax3 NC’s vs. absent NC.  
 
Further elucidation of these differences may be important in also explaining the 
pathogenesis leading to subsequent embryonic death typical in Pax3 mutants 
[15] but not seen in the ablated mutants. Pax3 mutants all die by E14 and exhibit 
NT defects similar to chick surgical ablations that die ~day 8 and encompass a 
larger NT ablation [6, 14, 18]. Both the Pax3 and Wnt1Cre/DTA mutants were 
bred on the same mixed genetic background (C57Bl6/129). Thus, observed 
differences in embryonic lethality were not influenced by background. NC marker 
analysis in Wnt1Cre/DTA mutants revealed that, unlike surgically ablated chick 
embryos, there is presence of Sox10-positive NC derivatives at E13.5 that 
appear to have emigrated from the NT prior to Wnt1Cre/DTA-mediated ablation. 
Sox10 is an established marker for NC-derived Schwann cells and is important in 
peripheral neuronal differentiation during development [93, 94]. Also, Sox10 is 
believed to interact cooperatively with Pax3 [94], and we have already 
established that Sox10 mRNA levels are diminished in Pax3 mutants 
(unpublished data) most likely due to their severe lack of NC-derived Schwann 
cells and dorsal root ganglia. Thus, in order to understand the differences in 
temporal lethality between these two models, follow up studies comparing 
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differences in peripheral neuronal differentiation between Pax3 and 
Wnt1Cre/DTA mutants, and the potential effect of this on in utero lethality due to 
poor cardiac output were performed (described in detail in Chapter III). In 
addition, follow up marker analysis at earlier stages of NC migration (prior to 
E13) in Wnt1Cre/DTA mutants may be informative in determining the temporal 
origin of these NC derivatives. Collectively, these data indicate that Wnt1Cre-
expressing CNC lineage is indeed required for normal structural heart 
development, as ablation leads to PTA/VSD and recapitulates the Pax3 mutant 
OFT defects.  
 
Given the failure of Wnt1Cre to capture this earlier population of migratory NC, 
the fact that Pax3f/d5/Wnt1Cre conditional mutants failed to recapitulate the 
OFT/AAA phenotypes of the Pax3d5/d5 systemic mutants is less surprising. Given 
the important role of CNCs for OFT septation, the PTA defect observed in 
Pax3d5/d5 embryos suggests Pax3 is required for heart development via 
influencing CNC behavior. Also, the fact that these conditional mutants displayed 
defects in melanocyte differentiation, suggests a possible variation in 
spatiotemporal requirements for Pax3 in different lineages. However, the 
absence of fully penetrant OFT/AAA phenotypes even in Pax3f/d5/AP2aCre 
conditional mutants is difficult to explain. Ap2aCre is expressed slightly earlier 
(~E8.0) than Wnt1Cre and should in theory have been able to successfully ablate 
Pax3 in all CNC-lineages. Although unexpected, the lack of fully penetrant 
OFT/AAA defects raises several intriguing questions concerning the role Pax3 
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plays in CNC morphogenesis and OFT septation. Recent studies involving the 
use of Wnt1Cre to restore Pax3 enhancer function in the NC in an already Pax3-
deficient environment [95], suggest that the Wnt1Cre-expressing population of 
NC cells is sufficient to regulate OFT remodeling when these cells are properly 
specified. Taken together, the results of this project demonstrate that Pax3 is 
required in a CNC-cell autonomous role during heart development. 
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Scheme 1: Cre-inducible lineage mapping using ROSA26R-LACZ (R26R-lacZ) 
reporter/promoter mice. NTR = non-translated region of IRES (internal ribosome 
entry site) sequence. 
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Scheme 2: Cre-inducible genetic ablation using ROSA26R-EGFP-DTA (R26R-
DTA) reporter/promoter mice. NTR = non-translated region of IRES (internal 
ribosome entry site) sequence. 
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Figure 4: Characterization of Pax3d5 allele  
(A) Western showing wildtype Pax3 protein is reduced in heterozygotes (d5/+) 
and absent in Pax3d5/d5 mutant E10.5 embryos, but that closely related Pax7 
protein and housekeeping actin expression is unaffected. (B) Heterozygote 
mutant mice exhibit white spots on their forehead and belly. (C) d5/d5 
homozygous embryos were present in normal Mendelian ratios at E13.5 but died 
thereafter. Nulls exhibited exencephaly (Ex) and spina bifida (Sb) NT defects.  
(D, E) NC-derived dorsal root ganglia are hypoplastic in d5/d5 homozygote 
embryos (E), when compared to normal littermate controls (D). (F-I) H&E staining 
of E13.5 wildtype (F, H) and mutant (G, I) heart sections showing PTA and VSDs 
in Pax3d5/d5 hearts. Ao = aorta, Ex = exencephaly, drg = dorsal root ganglia, nt = 
neural tube, p = pulmonary artery, PTA = persistent truncus arteriosus, VSD = 
ventricular septal defect. (Western performed by Dr. Hong-Ming Zhou, PhD). 
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Figure 5: Ink injection analysis of aortic arch artery formation and 
remodeling during OFT morphogenesis  
 (A-C) E10.5 AAA system is revealed. Note normal AA formation in both -/- (A, B) 
and wildtype (C). (D, E) However, in E11.5 Pax3 deficient embryos (E), the left 
6th AA has abnormally regressed. (F-H) E13.5 Pax3 deficient embryos all have 
PTA (single vessel exiting the right ventricle with concomitant VSD), but exhibit a 
range of types (Type-I in G, Type-III in H), when compared to wildtype littermates 
that have separate aorta and pulmonary trunks exiting the respective right and 
left ventricles. dA = dorsal aorta, oft = outflow tract, LV = left ventricle, RV = right 
ventricle. (Ink injections performed by Dr. Simon J. Conway, PhD). 
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Figure 6: Lineage mapping of lacZ stained CNC and their derivatives 
(marked via Wnt1Cre;R26R reporter)  
(A-H) Wnt1Cre;R26R lineage mapping. Dorsal (A) and left lateral (B) views of E9 
embryos showing impaired Pax3d5/d5 CNC migration when compared to wildtype 
littermates. (C) Right lateral views of E9.5 +/+, +/d5 and d5/d5 littermates 
showing fewer CNC populate the 3rd/4th/6th pharyngeal +/d5 arches, and still even 
less the d5/d5 arches. (D, E) Sections going through OFT region of E9 embryos 
shown in (C) reveal lack of Wnt1Cre-marked CNC in aorticopulmonary septum 
and OFT cushions. (F) Lateral view of E12 wildtype and null embryos, illustrating 
wide-ranging NC reduction and spina bifida (Sb) and exencephaly (Ex) in nulls. 
(G, H) Note reduction in E12 null OFT colonization, viewed frontally (G) and from 
the right (H). (I) Reduced CNC colonization is most evident in E13.5 -/- hearts (J, 
K). 
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Figure 7: Lineage mapping lacZ stained CNC and their derivatives (marked 
via Ap2aCre;R26R reporter)  
(A-H) Ap2aCre;R26R lineage mapping. (A-B) Left lateral views of E10.5 embryos 
showing impaired Pax3d5/d5 CNC migration when compared to wildtype 
littermates. Note lack of migratory CNC (red asterisk in B) and reduced drg (black 
asterisk in B). Histology reveals slightly reduced Ap2aCre-marked cells in mutant 
3rd arch (black asterisk in D), appreciably reduced in mutant 4th arch (asterisk in 
F) and completely absent in mutant 6th arch (H). Note reduced lacZ-positive cells 
in mutant OFT (F). dA = dorsal aorta, drg = dorsal root ganglia, fore = foregut, oft 
= outflow tract, t = truncus, *left 3rd/4th/6th arches respectively. 
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Figure 8: Genetic ablation of NC lineage in Wnt1Cre/DTA mutants  
(A-C) Wnt1Cre/DTA mutant (A), R26R-DTA only littermate control (B) and 
Wnt1Cre only littermate control (C) whole fetuses at E15.5 under UV. Note lack 
of craniofacial structures, internalized eyes following genetic NC ablation 
(arrowhead in A). Insets show same embryos under bright light. (D-E) Control (E) 
and mutant (D) transverse sections stained with anti-smooth muscle actin and 
counterstained with methyl green. Note enlarged OFT valve leaflets in mutant 
(asterisks in D). (F-G) Control (G) and mutant (F) transverse H&E sections 
showing VSD in mutants.  Ao = aorta, p = pulmonary artery, PTA = persistent 
truncus arteriosus, lv = left ventricle, rv = right ventricle, VSD = ventricular septal 
defect. (Wnt1Cre/DTA transgenic crosses were performed by Dr. Paige Snider, 
PhD; histology performed by Mica Gosnell). 
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Figure 9: NC lineage mapping and AAA analyses in Wnt1Cre/DTA mutants  
(A-C) Lineage mapping of Wnt1Cre positive cells in triple Wnt1Cre/R26R-
DTA/R26R-lacZ reporter mice shows efficient ablation of cells. (A) At E8.5, the 
only few Wnt1Cre cells remaining are in the head (arrowhead in A). Note lack of 
Wnt1Cre expression in region corresponding to trunk NC site of formation 
(asterisk in A) in the E8.5 control embryo. (B) By E9.5, the lacZ-positive 
Wnt1Cre-expressing cells are almost completely gone within the ablated embryo 
compared to control (C). (D-I) Ink injections on 3 individual Wnt1Cre/DTA mutant 
embryos at E11 reveal randomized defects in left-right AAA remodeling. (D, E) 
Ink injection reveals just 1 arch artery on both sides in 1 mutant. (F, G) Ink 
injection reveals right 3rd/6th AAA’s and left 1st/3rd/4th AAA’s in 1 mutant. (H, I) Ink 
injection reveals right 1st/2nd/3rd/4th/6th AAA’s and left 1st/2nd/3rd/4th/6th AAA’s in 1 
mutant. lv = left ventricle, lb = limb bud, ra = right atria, rv = right ventricle 
(numbers indicate position of AAA’s). (Ink injections performed by Dr. Simon J. 
Conway, PhD). 
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Figure 10: In situ hybridization analysis of NC markers in Wnt1Cre/DTA 
mutants.  
Wildtype (left panels) and Wnt1Cre/DTA mutant (right panels) show differential 
expression of NC markers in E13.5 embryos. Transverse sections showing lack 
of expression of Wnt1 and Pax3 in mutant NT’s compared to controls (red arrows 
in top and middle panels). Expression of Sox10 is completely absent in mutant 
drg (lower panel), but still present in a few migratory NC that have presumably 
escaped Wnt1Cre-mediated ablation (red circle in lower panel). (drg: dorsal root 
ganglia).  (In situ hybridization performed by Jian Wang). 
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Figure 11: Analysis of Pax3f/d5/Wnt1Cre conditional knockout. 
Wnt1Cre/R26R-lacZ lineage mapping of wildtype (A-C) and Wnt1Cre conditional 
mutant (D-F) NC. CNC colonization of E10.5 mutant 4th and 6th
 
AAA’s is 
equivalent to wildtype, but E11.5 mutants exhibit disorganized Schwann cell 
morphogenesis and clump on neurons (arrows in E). Conditional mutants also 
exhibit exencephaly (D&F), but are otherwise identical to wildtype littermates. 
(G&H) In situ hybridization at E10 using a Pax3 exon5-specific probe on 
conditional mutant (H) and control (G). Note d5 transcripts are missing in dorsal-
most neural tube (arrow in G), but present in somites. Phase contrast images are 
inset to verify tissue integrity. (I&J) Immunohistochemistry at E10 using a Pax3 
antibody on conditional mutant (J) and control (I).  (K&L) P10 pups showing 
pigmentation defects in mutants (inset in L) compared to littermate control (inset 
in K). LacZ-staining revealed melanocytes (arrow in K) in control epidermal basal 
layer (*) that are positive for melanin (brown). Mutants exhibit lacZ-positive 
melanocytes at similar densities but are all negative for melanin synthesis (L). ex 
= exencephaly, som = somite. (Pax3f/d5/Wnt1Cre data generated by Dr. Hong-
Ming Zhou, PhD). 
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Figure 12: Analysis of Pax3f/d5/AP2aCre conditional knockout. (A-C) 
AP2aCre/R26R-lacZ lineage mapping in wildtype embryos shows colonization of 
lacZ-positive cells in E8 neural folds (A) and E10.5 OFT (B&C). (D-G) 
AP2aCre/R26R-lacZ lineage mapping in wildtype (D&E) and conditional mutant 
(E&G) embryos at E10.5. Note reduced CNC colonization of E10.5 mutant 4th 
and 6th
 
AAA’s (arrow in G) compared to wildtype (arrow in E). Conditional 
mutants also exhibit exencephaly (D&F). (H-M) Histological analysis of 
transverse sections of embryos shown in (D-G). Reduced CNC colonization of 
OFT region in conditional mutant (I) compared to control (H). Conditional mutants 
display DORV/VSD (L&M) and enlarged OFT cushions (asterisk in L). Ao = aorta, 
ex = exencephaly, fore = foregut, lv = left ventricle, oft = outflow tract, otic = otic 
sulcus (presumptive ear), rv = right ventricle (numbers indicate position of 
AAA’s). (Pax3f/d5/AP2aCre data generated by Dr. Hong-Ming Zhou, PhD). 
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Chapter III: Beta-adrenergic signaling is essential for maintaining 
embryonic cardiac output and in utero viability  
 
1. Abstract 
 
The origins of heart failure in newborns are linked to malformations present 
before birth or acquired postnatally. Congenital malformations are due primarily 
to aberrant gene expression, which ultimately leads to poor cardiac output both in 
utero and after birth. However, there is still much to understand about the 
etiology of CHDs and their link to embryonic heart failure and eventual prenatal 
lethality. In this study, two mouse models of NC deficiency were used as tools to 
study the mechanisms underlying CHDs in utero with a particular focus on the 
novel role of NC on myocardial homeostasis during early embryonic 
development. The first mouse model is a Pax3 systemic knockout (Pax3d5/d5). 
Homozygous embryonic mutants display 100% embryonic lethality by embryonic 
day 14 (E14.0) accompanied by defects in OFT septation, PTA/VSD, EC-
coupling, NT closure, PNS and adrenal development. The second mouse model 
is a genetic ablation model using a Wnt1Cre-activated ROSA26-diphtheria toxin 
fragment-A (R26R/DTA) cell-killing system. Ablation of Wnt1Cre-expressing NC 
generated fully penetrant PTA/VSD defects. However, ablated mutants 
(Wnt1Cre/DTA) survived to birth (well past the E14.0 lethality observed in 
systemic Pax3 mutants). This difference in temporal lethality led to the 
examination of the underlying cause of poor cardiac function and eventual 
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embryonic death in Pax3 mutants. Based on molecular comparison of these two 
models, the underlying cause was determined to be insufficient stimulation of the 
beta-adrenergic pathway due to significantly reduced levels of circulating 
catecholamines in affected Pax3 mutant embryos. As a result, pharmacological 
rescue to birth of these embryos was made possible via administering 
isoproterenol (a synthetic catecholamine) or forskolin (a pro-adrenergic stimulant) 
to pregnant dams. This study is the first of its kind to conclusively delineate the 
role of Pax3-mediated NC deficiency in pathogenesis of embryonic heart failure 
and eventual in utero lethality.  
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2. Introduction 
 
Congenital heart defects (CHDs) are the most common birth defect in humans, 
present in approximately 1% of all live births and up to 10% of stillbirths [96]. 
Although a profundity of literature exists on the pathogenesis of heart failure in 
the adult, less is known about the underlying causes in newborns [97]. 
Nevertheless, some progress in the field has been made on the etiology [98], 
diagnosis and repair [99] of CHDs in the newborn. Based on such reports, it is 
believed that heart failure in newborns is linked to malformations present before 
birth or acquired postnatally [100, 101]. These malformations are due primarily to 
aberrant gene expression [102], which can ultimately lead to poor cardiac output 
both in utero and after birth.  
 
The role of NC cells in heart development and their impact on CHDs is well 
studied. The NC is a multipotent and transient migratory lineage originating from 
the neuroepithelium, which borders the surface ectoderm and gives rise to the 
embryonic neural tube [5]. They give rise to an array of different cell types, 
tissues, and organs [1, 2]. Different subpopulations of NC have been identified 
based on their rostrocaudal position of origin along the axis of the developing 
embryo, their specific properties, and the nature of their derivatives. The 
developing neural tube extends in a rostral to caudal direction beginning at the 
mid-diencephalon. As a result, NC cells have been broadly subdivided into 
cranial, cardiac, trunk and vagal crests [5]. The aim of this project was to focus 
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primarily on the roles of both cardiac and trunk NC cell populations on regulating 
myocardial structure and function respectively. A specific emphasis was placed 
on the importance of these two aspects of cardiogenesis in preventing embryonic 
lethality due to poor cardiac output. 
 
Previous studies [64, 65, 67] have shown that Gata3, Th, and Dbh mutants die 
by E11 due to deficiencies in noradrenaline levels. Specifically, Th and Dbh 
mRNA was reduced, leading to overall reduction in catecholamine synthesis and 
subsequent noradrenaline levels. Furthermore, pharmacological recue of in utero 
lethality was possible by feeding pregnant dams with L-DOPA, which is a 
catecholamine intermediate. Similarly, dying catecholamine-deficient fetuses 
have been rescued to birth via isoproterenol (a beta-adrenergic receptor agonist) 
feeding, as beta-adrenergic receptors are expressed in embryonic hearts [103]. 
The authors of this study postulated that the observed lethality, which was 
directly due to a significant deficiency in catecholamine levels, was caused by an 
underlying failure of trunk NC cells to properly give rise to developing 
sympathetic neurons, adrenal chromaffin cells and enteric neurons. Also, more 
recent studies demonstrated that Insm1 mutants have delayed differentiation of 
NC-derived sympatho-adrenal precursor cells, reduced levels of both Th and Dbh 
(markers of differentiation of sympathetic neurons) and are upstream of such 
noradrenaline compounds as norepinephrine [104]. Furthermore, restoration of 
normal noradrenaline levels was possible by feeding agonists to pregnant dams. 
This clearly demonstrated that reduced noradrenaline levels were responsible for 
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Insm1 mutant embryonic lethality. However, these studies never determined the 
direct molecular pathogenesis of the lack of norepinephrine at these early stages 
on poor embryonic cardiac output and function. Nor did they conclusively link the 
role of trunk NC cell differentiation in regulating sympathetic innervation of the 
heart during early stages of cardiogenesis, and how such innervation may be 
important in embryonic cardiac output. 
 
To address these concerns, a novel Pax3 allele was utilized ([87, 88]; described 
in Chapter II), which allowed for the generation of homozygote systemic Pax3 
delta-exon5 (Pax3d5/d5) knockout mice. This mouse line was then compared to 
the Wnt1Cre/DTA mouse line ([89]; described in Chapter II), which allowed for 
permanent, genetic ablation of the Wnt1Cre-expressing NC lineage in the 
developing embryo. The results of this project, for the first time, conclusively 
describe the indirect role that Pax3 plays in regulating embryonic cardiac output 
as well as the underlying cause of embryonic lethality in Pax3 mutants. In so 
doing, it is the first of its kind to provide significant insight into understanding the 
role that CNC-extrinsic factors play in regulating myocardial function during 
development. 
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3. Materials and Methods 
 
3.1. Mouse colonies, breeding, genotyping and PCR 
The Pax3 floxed conditional allele was generated as previously described [87, 
88]. Exon 5 of the Pax3 gene, which encodes the Pax3 homeodomain, was 
flanked by 5’ and 3’ loxP sites. This allowed for Cre-mediated removal of the 
floxed Pax3 homeodomain. To selectively remove the floxed allele in the 
germline, adult male heterozygous floxed Pax3 (Pax3f/+) mice were crossed to 
female C57Bl6/129 Tie2Cre-positive females to generate heterozygous delta 
exon 5 Pax3 (Pax3d5/+) adult mice. The resultant Pax3d5/+ males were crossed to 
wildtype C57Bl6/129 females to remove the Tie2Cre transgene. Pax3d5/+ 
(Tie2Cre-negative) mice were then intercrossed to generate Pax3d5/d5 mutant 
embryos. PCR screening strategy was used as previously described [88]. The 
Pax3d5/+ mice were then crossed into the Wnt1Cre mouse [4] to carry out lineage 
mapping studies (Scheme 1). The R26R-lacZ reporter mice were obtained from 
Jackson Laboratories (JaxLab stock #003474) and the ROSA26-eGFP-DTA 
(R26R-DTA) mice were generously gifted by A. Copp (University College 
London, England). The R26R-DTA was made by introducing an eGFP-DTA 
(enhanced green fluorescent protein-diphtheria toxin fragment A) cassette into 
the ubiquitously expressed ROSA26 reporter locus [89].  As a result, R26R-DTA 
mice express eGFP ubiquitously, but diphtheria toxin A-chain (DTA) is switched 
on only when Cre is present to remove the floxed stop codon sequence in front of 
DTA-encoding sequence (Scheme 2). To generate the Wnt1Cre/DTA ablated 
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mutant embryos, Wnt1Cre mice were crossed into the R26R-DTA mouse line to 
produce progeny that were both Wnt1Cre-positive and R26R-DTA positive. All 
mouse colonies for this study were maintained on a mixed C57Bl6/129 genetic 
background. Mice were housed and handled in accordance with Indiana 
University Institutional Animal Care and Use Committee guidelines. For timed 
pregnancies, the day of observed vaginal plug was designated embryonic day 
0.5 (E0.5). 
 
3.2. Histological immunohistochemistry and in situ hybridization  
Embryos were fixed in 4% PFA overnight at 4°C and processed for paraffin 
histology as previously described [90]. Immunohistochemistry was carried out 
using ABC kit (Vectastain) with DAB and hydrogen peroxide as chromogens. The 
endogenous peroxidase was quenched via incubation in 0.3% hydrogen peroxide 
in methanol for 30min. Dilutions of primary antibody were 1:10000 for mouse 
anti-αSMA (Sigma), 1:500 for rabbit anti-Th (Cell Signaling), 1:1000 for 
secondary anti-mouse and 1:1000 (Jackson Labs) for secondary anti-rabbit 
antibody (Jackson Labs). Incubation in primary antibody was carried out at 4°C 
overnight, and incubation in secondary antibody at room temperature for 30 
minutes. Radioactive in situ hybridization for ANF expression was performed as 
previously described [91]. Both sense and antisense 35S-UTP-labeled probes 
were used as negative controls and experimental samples respectively. Analyses 
were performed on serial sections within at least three independent embryos of 
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each genotype. To quantify expression differences, silver grains were counted 
per square area on serial sections and averaged. 
 
3.3. Wholemount X-gal (lacZ), immunostaining and in situ hybridization  
For X-gal staining, whole embryos were fixed in 4% PFA immediately after 
dissection for 2h. They were then washed 10min in PBS and subsequently 
washed 2x in β-gal buffer (0.058 M Na2HPO4, 0.042 M NaH2PO4, 0.001M 
MgCl2, 0.01% NP40), 5mins each. An additional wash was done overnight at 
4°C, then embryos were changed into X-gal substrate (0.1% X-gal, 0.005M 
K3Fe(CN)6, 0.005M K4Fe(CN)6, 0.001M EGTA), and incubated at 37°C in the 
dark. Embryos were then fixed in 4% PFA after successful X-gal staining was 
completed. Wholemount immunostaining for anti-neurofilament was performed 
by fixing embryos in methanol:DMSO (4:1) solution to allow for efficient 
permeabilization. Embryos were then processed into methanol for storage, or 
rehydrated for immediate staining. For staining, anti-neurofilament antibody 
(1:200, Sigma) was incubated at 4°C overnight. After color intensification with 
0.03% H2O2, embryos were post-fixed in 4% PFA. For wholemount in situ 
hybridization, embryos were stored in 100% methanol, then rehydrated and 
digested in proteinase K. Embryos were processed following routine procedures 
as previously described [105, 106] into prehybridization buffer (Formamide, 20X 
SSC pH 4.5, yeast tRNA, 50 g/mL Heparin with DEPC H2O, 10% SDS) at 70°C 
for up to 15h. Both Ncx1 and α1c antisense and sense probes were used as 
experimental and negative controls respectively.  
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3.4. Western and RT-PCR analyses 
Westerns were performed using mouse monoclonal anti-serca2a (1:500, Sigma), 
rabbit polyclonal anti-Th (1:1000, Cell Signaling), rabbit polyclonal phospho- and 
total- anti-phospholamban, anti-troponin I, and anti-ERK 1/2 (1:1000, Cell 
Signaling). All antibodies were incubated 1h at room temperature, except for 
phospho-antibodies which were incubated at 4°C overnight. To confirm equal 
loading, mouse monoclonal anti-β-tubulin antibody (1:10000, Roche) was used. 
Secondary HRP-conjugated goat anti-mouse and goat anti-rabbit IgG (Jackson 
Laboratories) were used. Antibodies were detected using the enhanced 
chemiluminescence (ECL) plus detection system (Amersham). To maintain equal 
loading between blots, membranes were stripped after each blot using stripping 
buffer (Thermo Scientific) at 55°C for 30min, and then subsequently oscillated for 
additional 30min, before being blocked in 5% milk dissolved in 0.1% PBS-
Tween20 and reprobed. Densitometry of immunoreactive bands was performed 
using Image J 1.37v (NIH). RT-PCR analyses was performed on cDNA 
synthesized from RNA extracted from isolated E13 embryo hearts of control, 
mutant and mutant treated with isoproterenol (n = 3). This was done using a 
Superscript-II kit (Invitrogen) with 5μg RNA samples and random primers 
(Invitrogen). cDNA samples were mixed with SYBR green PCR master mix 
reagent (Roche) and amplified in 96-well plates, using a Lightcycler machine 
(Roche). To ensure specific amplification, specific primers for b1ar (forward 
primer 5’ - CGA GCT CTG GAC TTC GGT AG - 3’ and reverse primer 5’ - GGC 
ACG TAG AAG GAG ACG AC - 3’), b2ar (forward primer 5’ - AAG AAT AAG 
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GCC CGA GTG GT - 3’ and reverse primer 5’ - GTC TTG AGG GCT TTG TGC 
TC - 3’), ac5 (forward primer 5’ - ACA ACA TTC TGC CCA AGG AC - 3’ and 
reverse primer 5’ - CAT TTG GTC CAT CAG CTT CA - 3’), ncx1 (forward primer 
5’ - CAA TTG CTT GTC TTG GGT CA - 3’ and reverse primer 5’ - TCA 
CTC ATC TCC ACC AGA CG - 3’) and ryr2 (forward primer 5’ - CAC ATG GAC 
GAT GGT TTG AA - 3’ and reverse primer 5’ - TGT TCT GCT TGT CCT 
CAT GC - 3’) were used. Amplification signals for all primer products were 
normalized with levels of GAPDH.  
 
3.5. HPLC and PKA activity assays  
HPLC analyses were performed as previously described [107]. Embryos were 
harvested and immediately placed into liquid nitrogen. Frozen embryos were 
homogenized in cold buffer (2M Tris, pH 8.6; 5mg activated alumina). Samples 
were vortexed, centrifuged and supernatant discarded. Alumina was transferred 
to a 0.22-μm Ultrafree MC filter (Millipore) and washed in distilled H2O. 
Catecholamines were eluted using cold 0.2 N perchloric acid and then re-
centrifuged through a fresh 0.22-μm Ultrafree filter at 5,000 rpm for 10 min at 
4°C. Catecholamines were separated by HPLC on a 3 × 150-mm (3 μm) C-18 
column (ESA) at a flow rate of 0.5 ml/min at room temperature with MD-TM 
mobile phase (ESA) and quantified by electrochemical detection (EC) using an 
ESA model 5020 guard cell set to +350 mV, followed by an ESA model 5014B 
analytical cell (electrode 1 at −150 mV and electrode 2 at +220 mV). The data 
are expressed as average (+/- standard error) norepinephrine and dopamine 
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concentration (pmol/embryo) normalized to DHBA (3,4-Dihydroxybenzylamine). 
PKA activity assays were performed using SignaTECT PKA Assay system kit 
(Promega) following manufacturer’s instructions. Briefly, embryos were 
homogenized in 5ml cold extraction buffer (25mM Tris-HCl, pH 7.4; 0.5mM 
EDTA; 0.5mM EGTA; 10mM β-mercaptoethanol; 1ug/ml leupeptin; 1ug/ml 
aprotinin), centrifuged (5min, 4°C, 14000 x g) and supernatant was kept.  
Supernatant enzyme preparations were radioactively labeled using γ-32P-ATP 
(3000Ci/mmol) 10uCi/ul and serially diluted in 0.1mg/ml BSA, before incubating 
for 5min at 30°C with reaction mix (provided by manufacturer) +/- 5ul/reaction of 
0.025mM exogenous cAMP. To ensure specificity, biotinylated Kemptide 
(LRRASLG), which is a known specific target of PKA, was used as substrate in 
the reaction. Incubated samples were then spotted onto SAM® (Streptavidin-
biotinylated biotin capture Membrane) paper. Spotted SAM blots were washed 3x 
in 2M NaCl, and then in 2M NaCl in 1% H3PO4. SAM blots were dried at room 
temperature for 30min or under a heat lamp for 5min, then total radioactive 
counts were determined. Counts were done by placing blots into scintillation vials 
containing 1ml scintillation fluid (ScintiVerse cocktail, Fisher) and measured 
using a scintillation counter machine (Beckman Coulter LS 6500). PKA enzyme 
activity was measured in pmol/min/ug of protein relative to specific activity of γ-
32P-ATP. 
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3.6. Proliferation analyses 
Cell proliferation analyses were performed using Ki67 and BrdU incorporation.  
For Ki67 staining, monoclonal rat anti-Ki67 antibody (1:25, DakoCytomation) was 
used. For detection, sections were boiled in 1x antigen retrieval buffer (Dako) for 
20min and then cooled to room temperature prior to blocking. BrdU analysis was 
performed by injecting pregnant dams with reagent (Invitrogen) at a 
concentration of 1ml/100g mouse body weight for 1h prior to harvesting embryos. 
Embryos were processed for routine paraffin sectioning. Incorporated BrdU was 
detected using mouse anti-BrdU antibody (2 drops/section, Zymed) following 
manufacturer’s instruction. Detection of antibody localization was performed 
using ABC kit (Vectastain) with DAB and hydrogen peroxide as chromogens. For 
comparison of both Ki67 and BrdU staining, sections from age-matched 
littermate embryos for each genotype (n = 3) were used. For quantification of 
both assays, positive cells were counted per square area on serial sections and 
averaged.  
 
3.7. Echocardiography functional analysis 
For echocardiography analysis, pregnant dams were anesthetized using 3% 
isoflurane / 97% oxygen for initial induction and maintained on 1-2% isoflurane / 
98% oxygen. Regular monitoring of effectiveness of anesthesia was done by 
checking for pinch or stretch reflexes. For measurements, Visualsonics Vevo 770 
machine was used operated by Visualsonics Vevo software version 3.0. For 
detection of embryonic signals, imaging was performed using Probe # RMV-704 
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at 40MHz. To avoid background, mouse chest hair was removed using a spatula 
after application of Nair shaving cream. For this study, 9 litters were analyzed 
(E13.5 – 16.5), and data obtained from all experimental embryos were compared 
only to their littermate controls.  
 
3.8. Mouse surgical implantation of osmotic mini-pumps 
Pregnant dams were anesthetized using 5% isoflurane / 95% oxygen for initial 
induction and maintained on 3% isoflurane / 97% oxygen. Regular monitoring of 
effectiveness of anesthesia was done by checking for pinch or stretch reflexes. 
Beta-dyne was used to sterilize the surgical incision site. Osmotic 7-day mini-
pumps (Alzet 2001, flow rate ~1ul/h) filled with saline or isoproterenol (28mg/ml 
in saline) or forskolin (3.4mg/ml in 70:30 DMSO:Saline) were implanted 
subcutaneously into pregnant dams at the 8.5 day-stage or 10.5 day-stage of 
gestation. For survival studies, embryos were harvested E14.5 onwards. For 
molecular analytical studies, embryos were harvested at the time-point required 
for study (E10.5, E12.5, E13 and E16.5). For duration studies, mini-pumps were 
removed at E10.5 (2 days post-implantation) and embryos were harvested at 
E14.5 onwards; alternatively, mini-pumps were implanted at E10.5 and embryos 
harvested E14.5 onwards.  
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4. Results 
 
4.1. Pax3d5/d5 mutant embryos display early signs of embryonic heart failure 
As mentioned earlier (Chapter II), Pax3 mutant embryos display defects in OFT 
remodeling (PTA) and NT closure (exencephaly, rachischisis / spina bifida) 
(Figure 13A-D). In order to assess the effects, if any, of Pax3 deletion on heart 
functional development, in situ hybridization for ANF (a marker for heart failure) 
was performed on E13 mutant and control hearts. Results indicate a significant 
increase in ANF mRNA expression in both the atrial and ventricular myocardium 
of Pax3 mutant hearts compared to littermate controls (13E, F). In order to 
determine the temporal origin of the pathogenesis of heart failure, marker 
analyses were performed on earlier stage embryos (E9). Based on wholemount 
in situ hybridization using α1c and Ncx1, it was determined that as early as E9, 
Pax3 mutant hearts display defects in EC-coupling as expression of these 
markers were both appreciably increased in mutant hearts compared to littermate 
controls (13G, H). In order to determine the effect of misexpression of these 
markers on myocardial structure, histological and proliferation analyses was 
performed on E12.5 mutant and control hearts. However, based on results from 
both Ki67 and BrdU staining, no observable differences were found in 
proliferation levels (13I, J). Furthermore, the myocardium appeared intact and 
normal in mutants analyzed at this stage compared to their littermate controls.  
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4.2. Pax3d5/d5 mutant embryos lack PNS derivatives  
As described previously (Chapter II), based on NC lineage mapping data 
performed using Wnt1Cre/R26R-lacZ, Pax3 mutants have reduced numbers of 
migratory NC and NC-derived structures. To follow up on these previous 
observations, this project focused primarily on the lack of NC-derived PNS 
structures and the potential effect this may have on cardiac output. Based on NC 
lineage mapping data, it was determined that Pax3 mutants have deficiencies in 
derivatives of the TNC, including the PNS, adrenal medulla and dorsal root 
ganglia (Figure 14A-E; 14G, H). NC lineage mapping results performed at E11 
revealed a severe lack of migratory NC contributing to the dorsal root ganglia, 
sympathetic ganglia and enteric neurons (14A-E). To confirm the effects of 
reduced numbers of NC, histological transverse sections of the dorsal root 
ganglia were analyzed at E10.5. X-gal staining confirmed fewer lacZ-positive 
cells colonizing the dorsal root ganglia in Pax3 mutants compared to controls 
(14G, H). As a result, the size of the dorsal root ganglia in Pax3 mutants was 
appreciably reduced. To determine the global effect of Pax3 deletion on PNS 
structure and function, wholemount anti-neurofilament (a neuronal marker of 
differentiation for the PNS neuronal network) staining was performed at E11. This 
revealed not just defects in structural organization of the PNS neuronal network 
in Pax3 mutants, but also in their ability to differentiate properly as levels of 
neurofilament expression were appreciably reduced (14F). In contrast to Pax3 
mutants that develop poor cardiac output, Wnt1Cre/DTA mutants appear to have 
no observable embryonic heart functional defects, as these embryos survive to 
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birth (Chapter II). In order to determine if Wnt1Cre expression could successfully 
ablate the population of TNC cells that fail to give rise to the defective structures 
in Pax3 mutants, NC lineage mapping analysis was performed (described in 
more detail previously in Chapter II). As mentioned previously, Wnt1Cre 
expression was determined to not be expressed in the region of NT that gives 
rise to TNC at early E8.5 stages. Thus, Wnt1Cre-mediated ablation only affected 
later waves (E9.5 onwards) of TNC cells originating from this region. This was 
due to a normal spatiotemporal delay in its rostrocaudal expression along the 
axis of the developing tube (14I). 
 
4.3. Pax3d5/d5 mutants display severe deficiencies in tyrosine hydroxylase 
and catecholamine levels 
To determine the role of this early (Wnt1Cre-negative) population of TNC on PNS 
development, sympathoadrenal differentiation and catecholamine levels were 
assessed. Based on immunostaining analyses using anti-Th antibody, it was 
determined that there is a lack of Th expression in Pax3 mutant adrenals when 
compared to Wnt1Cre/DTA adrenals (Figure 15A-C). This apparent deficiency 
appears to be due to a lack of formation or maintenance of the adrenal medulla 
in the Pax3 mutants. This indicates that the early subpopulation of TNC observed 
in Wnt1Cre/DTA mutants is capable of colonizing the adrenals and supporting 
normal adrenal development. As reported previously (Chapter II), even though 
there is a lack of NC migration in Pax3 mutants, there is still successful 
colonization (albeit in reduced numbers) of NC cells at the dorsal root ganglia 
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and neurons of the PNS network. In order to determine why these few NC cells 
were incapable of supporting sympathoadrenal development, analysis of Th 
expression in this subpopulation of cells was performed. Based on anti-Th 
immunostaining done on lineage mapped NC cells, it was determined that in 
addition to fewer TNC cells colonizing the dorsal aortae (the site of induction of 
TNC cells fated to develop along the sympathoadrenal lineage), these cells also 
failed to express proper levels of Th (15D-G). This indicates a Pax3-specific role 
in TNC specification and differentiation along the sympathoadrenal lineage. To 
determine the global effect of lack of differentiation of these cells on Th levels, 
whole embryo protein lysates were analyzed. Western analyses confirmed a 70% 
reduction in Th levels in Pax3 mutants as early as E10.5, and a progressive loss 
of Th expression up till E13 (15H, I). Th levels were also assessed by Western in 
whole embryo lysates extracted from E13 Wnt1Cre/DTA mutants. However, no 
significant differences were observed between mutants and littermate controls 
(data not shown). Since Th is a noradrenaline precursor, HPLC measurements 
were performed to determine the effect on global catecholamine levels in E13.5 
Pax3 mutants. HPLC data confirmed a 93% reduction in norepinephrine levels in 
Pax3 mutants compared to littermate controls. This reduction was determined to 
be Pax3-dose dependent as Pax3d5/+ heterozygote embryos displayed a 21% 
reduction in norepinephrine levels (Table 1). However, this slight reduction does 
not appear to be significant enough to cause lethality as Pax3 heterozygote mice 
are viable. Dopamine levels were also measured and determined to be slightly 
lower in Pax3 mutants. However, at these early stages, levels of dopamine were 
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too low to determine any significant difference between Pax3 mutants and 
controls.  
 
4.4. Pax3d5/d5 mutants are rescued to birth via isoproterenol or forskolin 
treatment 
To compensate for low fetal catecholamine levels, isoproterenol (a synthetic 
catecholamine) was administered to pregnant dams via mini-pump implantation. 
Since isoproterenol is permeable pass the maternal placenta, treatment of 
pregnant dams was capable of supplementing the observed reductions in 
catecholamine levels. More importantly, by doing so, Pax3 mutants were viable 
until birth. In order to achieve rescue, pregnant dams were treated as early as 
E8.5, and litters were analyzed from E14.5 (normal time-point of lethality) 
onwards. Analyses of treated litters (n = 40) revealed presence of Pax3 mutants 
in normal Mendelian ratios (~28%) from E14.5 until birth (Table 2). In order to 
determine the temporal window required for successful rescue, pregnant dams 
were treated as late as E10.5, and this was determined to be sufficient for 
rescue. Interestingly, only ~50% rescue of Pax3 mutants occurred when 
pregnant dams were treated at E8.5 and taken off the treatment at E10.5, 
indicating that from E10.5 onwards cardiac development has a critical 
requirement for normal catecholamine levels. Since catecholamines are 
important in beta-adrenergic stimulation, to determine the functional importance 
of the adrenergic pathway on early embryonic cardiac output, an alternative 
pharmacological approach was performed. To do this, isoproterenol treatment 
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was replaced with forskolin, which is a specific activator of adenylate cyclase, an 
important intermediary in the beta-adrenergic pathway. Surprisingly, forskolin 
treatment of pregnant dams was also capable of rescuing Pax3 mutants to birth. 
Analysis of litters (n=9) treated with forskolin revealed that Pax3 mutants were 
present in normal Mendelian ratios (~22%) from E14.5 onwards (Table 1). 
 
4.5. Structural defects persist in isoproterenol-treated Pax3d5/d5 mutants  
Despite pharmacological rescue by either isoproterenol or forskolin, treated Pax3 
mutants still displayed all of the classical structural defects associated with Pax3-
deficiency. Analysis of E18.5 isoproterenol-treated Pax3 mutants revealed a 
presence of NT defects (exencephaly, spina bifida) and hypoplastic limbs (Figure 
16A). In addition, based on NC lineage mapping analysis, there is still a 
deficiency in numbers of migratory NC at E10.5 (16B) and in formation of smooth 
muscle cells derived from Pax3-expressing somite-derived muscle progenitor 
cells (16C). Furthermore, due to lack of migratory NC cells, OFT remodeling 
defects are still present including PTA and accompanied VSD (16D-G). There 
was also a gross reduction in dorsal root ganglia size of treated mutants 
compared to littermate controls (16H, I). In summary, despite being viable until 
birth, treated Pax3 mutants are still structurally similar to untreated.  
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4.6. Echocardiography analyses reveal appreciably improved cardiac 
function in isoproterenol-treated Pax3d5/d5 mutants 
To determine the effect of isoproterenol treatment on cardiac output and function, 
echocardiography analyses was performed. Echo data confirmed poor cardiac 
function in Pax3 mutants at E13.5 (1 day prior to dying). Both cardiac contractility 
and heart rate were diminished in Pax3 mutants compared to littermate controls 
(Figure 17A, top and middle panels). However, isoproterenol treatment was 
capable of restoring normal cardiac output based on analyses performed at 
E16.5 on Pax3 mutants, which were functionally indistinguishable from their 
littermate controls (17A, lower panel). For this analysis, it was possible to 
correctly distinguish mutants from their littermate controls in utero. This was done 
by correctly identifying NT defects (exencephaly) in Pax3 mutants as early as 
E13.5 in utero (17B). 
 
4.7. Insufficient stimulation of the beta-adrenergic pathway is the 
underlying cause of poor cardiac output and subsequent lethality in 
Pax3d5/d5 mutants 
In order to determine the effect of reduced catecholamine synthesis and 
subsequent isoproterenol treatment on the embryonic beta-adrenergic pathway, 
extensive analysis of key molecular factors in the pathway was carried out. In the 
absence of dependable antibodies at these early stages, mRNA levels of 
molecular factors involved in the upstream beta-adrenergic pathway were 
analyzed. Based on RT-PCR analysis done on mRNA extracted from E13 
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isolated hearts, it was determined that mRNA levels of b1ar, b2ar and ac5 were 
significantly reduced in Pax3 mutant hearts compared to controls. However, 
these levels were normalized upon treatment with isoproterenol (Figure 18A). 
Since an increase in expression of both α1c and Ncx1 mRNA levels in E9 Pax3 
mutant embryos had been observed, analysis of downstream key elements in the 
beta-adrenergic pathway that are important in regulating calcium handling was 
also carried out. RT-PCR analysis using mRNA extracted from E13 isolated 
hearts revealed a similar increase in mRNA levels of Ncx1 and Ryr2 in Pax3 
mutant hearts. Similarly, these levels were normalized upon treatment with 
isoproterenol (18B). Since Echo studies had revealed improved cardiac function, 
markers important in regulating embryonic cardiac contraction / relaxation were 
examined. Specifically, phosphorylated levels of phospholamban (a regulator of 
Serca activity and cardiac relaxation) and phosphorylated levels of troponin I (a 
regulator of cardiac contraction) were identified as being important players in 
regulating embryonic contraction / relaxation. Based on Western analyses on 
protein samples extracted from E13 isolated hearts, it was determined that 
expression of these molecular targets was decreased in Pax3 mutant hearts. 
However, reduced levels of expression were normalized post-isoproterenol 
treatment (18C). Interestingly, no observable differences were observed in Serca 
protein levels between Pax3 mutant and control hearts. However, based on 
phospholamban results, it is unclear whether protein level is an adequate 
reflection of Serca activity. Although there was no observable difference in 
phosphorylated levels of ERK 1/2 between Pax3 mutant and control hearts, 
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isoproterenol treatment always led to a significant increase. As a result, as an 
internal technical control for all protein samples extracted from treated hearts, 
phosphorylated levels of ERK 1/2 were used to determine effective delivery and 
activity of the drug. 
 
4.8. Role of cAMP/PKA in regulating embryonic cardiac output and 
embryonic survival  
PKA activity assays were performed on whole embryo lysates at E12.5 to 
determine effect of PKA activity. It was determined that PKA activity was 
diminished by ~50% in Pax3 mutants compared to wildtype controls. These 
diminished levels were significantly increased by isoproterenol treatment (Figure 
18D). Furthermore, when embryo extracts were treated with 5ul exogenous 
cAMP (0.025mM), PKA activity increased in all groups. However, the PKA 
response to exogenous cAMP was still less in Pax3 mutants compared to 
wildtype controls. More interestingly, the response to cAMP in Pax3 mutants was 
greater than in Pax3 mutants treated with isoproterenol. This suggests that there 
is a rate-limiting response to both cAMP and isoproterenol treatment in Pax3 
mutants. 
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5. Discussion 
 
The results of this project have conclusively shown that low levels of 
norepinephrine lead to poor stimulation of the beta-adrenergic pathway, which 
causes poor cardiac output and eventual prenatal lethality. The importance of the 
beta-adrenergic pathway in survival was demonstrated by using two independent 
pharmacological approaches, which specifically targeted the embryonic pathway 
at two different cascade levels – the receptor levels (i.e., beta-receptors) and 
receptor targets (i.e., adenylate cyclase V). Via administering isoproterenol to 
pregnant dams, we were able to supplement maternal levels of catecholamine, 
which is necessary to have effective compensation of low levels in mutant 
embryos. In so doing, we demonstrated that we can effectively bypass the 
catecholamine synthesis pathway during development. Furthermore, by treating 
pregnant dams with forskolin, which specifically targets adenylate cyclase, we 
successfully demonstrated that the underlying cause of lethality was not directly 
due to low catecholamine levels. Rather it is due to the secondary effect of 
having low levels, which is a lack of sufficient adrenergic stimulation on the 
developing heart. To our knowledge, this is the first study to mechanistically 
demonstrate the important of adrenergic stimulation on embryonic cardiac output. 
 
This project, for the first time, definitively determined the underlying cause of 
heart failure in Pax3 mutants and subsequent lethality. Based on analyses done 
on early embryos, we determined that the onset of heart failure in these embryos 
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occurs prior to colonization of CNC, which conclusively rules out a CNC-intrinsic 
effect. The effect of Pax3-deficiency appears to not just be restricted to reduction 
in NC formation and migration; it also affects the ability of the few migratory NC 
cells to differentiate properly along the sympathoadrenal lineage, leading to an 
overall insufficiency in catecholamine synthesis. This suggests a Pax3-specific 
role in early NC specification and differentiation even at later stages of 
development when Pax3 expression is turned off. 
 
Beyond the effects of Pax3, our data is significant in delineating the dose-
dependent importance of catecholamine levels in embryonic heart function and 
survival. Through the use of two mouse models, we have elegantly demonstrated 
the presence of a required threshold level below which, embryonic heart function 
can not be supported. Building on previous studies that showed Th-
happloinsufficiency and subsequent noradrenaline deficiency lead to in utero 
lethality [64-67], we can now demonstrate a dose-dependent requirement of Th 
in maintaining embryonic cardiac output and survival. Since Th is important in 
catalyzing the initial rate-limiting step in catecholamine synthesis [69], it is no 
surprise that as Th levels are diminished in our different mouse models, we 
observed a corresponding drop in norepinephrine levels. This is further 
supported by the fact that Wnt1Cre/DTA mutants can survive to birth despite 
having an apparent fewer number of migratory NC cells compared to Pax3 
mutants. It appears that mere number of NC cells is not important when it comes 
to maintaining embryonic cardiac function. Instead, the origin and functional 
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ability of those crest cells to differentiate along the sympathoadrenal lineage is 
the key to embryonic survival. It is important to not confuse structural and 
functional development of the embryonic heart. As, while the numbers of 
migratory CNC is clearly important in supporting structural remodeling [2, 5, 18], 
the specification of TNC is more important in maintaining functional development 
of the heart. As a result, we can now state definitively that both the CNC and 
TNC are important during cardiogenesis. The CNC provides structural support to 
the heart, via its contribution to the ectomesenchymal cells of the 
aorticopulmonary septum [6] and the smooth muscle cells that surround the 
aortic arches [18, 19]. However, the TNC is also important in cardiac 
development, via its contribution to the adrenal medulla and sympathetic ganglia 
which innervate the dorsal aortae, and are both important in providing beta-
adrenergic stimulation to the heart.  
 
Additionally, we have identified the temporal window of catecholamine 
requirement during development. Despite early signs of EC-coupling defects by 
E9, Pax3 mutants could be treated as late as E10.5 and still survive to birth. 
However, only ~50% of mutants survived when treatment was initiated at E8.5 
(before onset of cardiac functional anomalies) and terminated at E10.5. This 
suggests that post-E10.5 gestational stage, catecholamine is critically required 
for embryonic cardiac output. This result is consistent with existing models of 
noradrenaline deficiency in which the onset of embryonic lethality occurs from 
E11 onwards [64-67, 69]. Future studies will focus on narrowing this time-window 
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even further, as determining the minimum dosage and duration of treatment to 
get the most optimal result may have significant clinical implications. 
 
Furthermore, we have identified downstream molecular targets such as 
phospholamban and troponin I as being important players in regulating 
embryonic cardiac contraction/relaxation. These molecular targets are 
misexpressed in Pax3 mutants, but normalized post-isoproterenol treatment. 
Also of interest are results from activity assays we have performed, indicating 
that cAMP/PKA activity is perturbed in Pax3 mutants but normalized post-
isoproterenol treatment. Ongoing studies are addressing the specific role of PKA 
by using a host of phospho-antibodies to determine which PKA isoforms are 
important and potentially identify which phosphorylation sites may play a role in 
regulation of embryonic cardiac output. Taken together, the results of this project 
demonstrate that proper TNC cell specification is required to support beta-
adrenergic stimulation of the developing heart, loss of which leads to poor 
embryonic cardiac output and eventual fetal lethality. This is the first study of its 
kind to link CNC-extrinsic factors to early embryonic cardiac function and 
survival. 
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Table 1: Measurement via HPLC of catecholamine levels. Performed on E13.5 
whole embryo lysates. Note dose-dependent decrease in norepinephrine levels 
corresponding to Pax3 levels. Each data set represents average value 
(pmoles/embryo), n = 5; * = p<0.05. (HPLC measurement performed in 
collaboration with Dr. Jay R. Simon, PhD).  
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Table 2: Summary of number of pharmacologically (via isoproterenol or forskolin 
treatment) rescued Pax3d5/d5 embryos (E14.5 – E18.5). Note rescued mutants 
are viable in Mendelian ratios. (Surgical implantations of osmotic mini-pumps 
performed in collaboration with Mark Soonpaa). 
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Figure 13: Structural and molecular analyses of Pax3d5/d5 mutants  
(A-D) Structural analyses of Pax3 mutant embryos show defects in NT and OFT 
formation. (A, B) Gross structural analysis at E12.5 shows NT defects including 
exencephaly (ex) and spina bifida (sb) in Pax3 mutants (B) compared to 
littermate control (A). (C, D) H&E histological analysis on transverse sections of 
embryos shown in (A, B) shows PTA in Pax3 mutants (D) compared to properly 
septated OFT into aorta (Ao) and pulmonary artery (P) in control (D). (E-H) 
Molecular analyses of embryonic heart function shows early abnormalities in 
Pax3 mutant embryo hearts. (E, F) ANF in situ hybridization on E13 transverse 
heart sections comparing wildtype (E) with mutant (F). Note significant 
upregulation in myocardium of mutant hearts. (G, H) Wholemount in situ staining 
of α1c (G) and Ncx1 (H) at E9 showing increased mRNA expression levels in 
mutants (right) compared to littermate controls (left). Note: arrows indicate 
misexpression of markers in mutant myocardium; asterisk indicates exencephaly 
NT defect in Pax3 mutants. (I, J) Proliferation analyses on E12.5 transverse heart 
sections. (I) Anti-Ki67 staining shows no observable difference in Pax3 mutant 
(right) and littermate control (left) myocardium. (J) BrdU staining shows no 
observable differences in Pax3 mutant (right) and littermate control (left) 
myocardium. Ao = aorta, ex = exencephaly, P = pulmonary artery, PTA = 
persistent truncus arteriosus, sb = spina bifida. (Radioactive in situ hybridization 
performed by Jian Wang). 
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 Figure 14: Pax3d5/d5 mutants display insufficient NC-derived PNS structures  
(A-E) NC lineage mapping analyses via Wnt1Cre/R26R-lacZ show lack of NC-
derived PNS structures in Pax3 mutants. (A) Gross analyses at E11 shows lack 
of PNS and enteric neurons in Pax3 mutant (left) compared to littermate control 
(right). Note: arrow indicates severe deficiency in migratory TNC-derived dorsal 
root ganglia structures. Note exencephaly (ex) and spina bifida (sb) in Pax3 
mutant embryo. (B, C) Higher magnification of lateral views of embryos shown in 
(A) shows disorganization of the reduced TNC-derived dorsal root ganglia (arrow 
in B) in Pax3 mutant (B) compared to littermate control (C). (D, E) Higher 
magnification of dorsal views of embryos shown in (A) shows disorganization of 
the reduced TNC-derived dorsal root ganglia (arrow in D) in Pax3 mutant (D) 
compared to littermate control (E). (F) Anti-neurofilament whole embryo staining 
at E11 on Pax3 mutant (left) and littermate control (right) showing gross 
deficiency and disorganization of NC-derived PNS structures. Note exencephaly 
(ex) and spina bifida (sb) in Pax3 mutant embryo. (G, H). NC lineage mapping 
analysis via Wnt1Cre/R26R-lacZ on E10.5 transverse sections counterstained 
with anti-αSMA. Note fewer migratory lacZ-positive cells in mutant (G) compared 
to littermate control (H) contributing to smaller dorsal root ganglia (drg) structures 
in mutant. Also note reduced NC-derived smooth muscle cells (brown anti-αSMA 
staining) in mutants. (I) NC lineage mapping via Wnt1Cre/R26R-lacZ on E8.5 
Wnt1Cre/DTA mutant embryo (left) and littermate control (right). Note lack of 
Wnt1Cre expression in region corresponding to trunk NC site of formation at this 
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stage (red square). drg = dorsal root ganglia, ex = exencephaly, NT = neural 
tube, sb = spina bifida.  
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Figure 15: Tyrosine hydroxylase is significantly reduced in Pax3d5/d5 
mutants but unaffected in Wnt1Cre/DTA mutant embryos  
(A-C) Immunohistochemistry analysis using anti-Th antibody on E13.5 transverse 
sections counterstained with methyl green going through the adrenals of control 
(A) Pax3 mutant (B) and Wnt1Cre/DTA mutant (C). Note severe lack of Th 
expression in Pax3 mutant adrenals (arrow B). (D, E) NC lineage mapping via 
Wnt1Cre/R26R-lacZ using anti-Th antibody on E11 transverse sections 
counterstained with methyl green. Note reduced number of migratory lacZ-
positive (dark blue) cells in Pax3 mutant (E) compared to littermate control (D).  
(F, G) Higher magnification of sections shown in (D, E) showing Th-positive 
(brown staining) NC-derived cells (dark blue) as they colonize the dorsal aorta in 
control (F). However, there is a slightly reduced number of NC-derived cells (dark 
blue) colonizing the dorsal aorta in Pax3 mutant (arrow in G). Note lack of Th 
expression (appreciably reduced brown staining) in the mutant NC cells that 
successfully colonize the Pax3 mutant dorsal aorta (arrow in G). (H) Western 
analysis on whole embryo lysates shows reduced Th protein levels in Pax3 
mutants compared to littermate controls at E13 and E10.5.  Each lane represents 
single whole embryo homogenized protein lysates. Equal loading between 
samples was confirmed with tubulin. (I) Stastical analysis on E10.5 westerns 
shown in (H) shows Th levels is reduced by 70% in Pax3 mutants (black bar) 
compared to littermate control (white bar). Each bar represents average value 
(+/- standard error) relative to control (normalized to 1), n = 2. mut = mutant, wt = 
wildtype. (Histology performed by  Mica Gosnell).  
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Figure 16: Histological analyses show structural defects in Pax3d5/d5 
mutants remain after isoproterenol treatment but they survive to birth 
(A-I) Structural analyses on Pax3 mutants treated after isoproterenol treatment. 
(A) E18.5 littermates treated with isoproterenol showing NT defects 
(exencephaly, rachischisis / spina bifida) and hypoplastic hypaxial muscles in 
limbs of Pax3 mutant (right) compared to control (left). (B) NC lineage mapping 
analysis via Wnt1Cre/R26R-lacZ on E10.5 littermate embryos treated with 
isoproterenol shows fewer migratory NC cells in mutant (right) compared to 
control (left). Note exencephaly (ex) and lack of migratory NC cells (black arrows) 
in mutant. (C) anti-αSMA staining on transverse sections on E18.5 limbs of 
embryos shown in (A). Note lack of smooth muscle cells (absent brown staining 
indicated by arrows on right) in mutant (right) compared to normal smooth 
muscle cells (present brown staining indicated by arrows on left) in control (left). 
(D-I) H&E histological analysis on transverse sections of E15.5 littermate 
embryos treated with isoproterenol. (D-G) Histological analysis on control (D, F) 
and mutant (E, G) hearts shows PTA (E) and accompanied VSD (G) in mutant 
hearts compared to normal septation in control hearts. (H, I) Histological analysis 
on control (H) and mutant (I) transverse sections going through the NT region 
shows misshapen NT and reduced dorsal root ganglia (drg) in mutant (I) 
compared to control (H). Ao = aorta, drg = dorsal root ganglia, P = pulmonary 
artery, PTA = persistent truncus arteriosus, VSD = ventricular septal defect.  
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Figure 17: Echocardiography analyses show poor cardiac function in 
Pax3d5/d5 mutants are rescued by isoproterenol treatment  
(A) Fetal M-mode echocardiogram analyses on E13.5 littermates of control (top 
panel) and Pax3 mutant littermates (center panel). E15.5 Pax3d5/d5 mutant 
treated with isoproterenol (bottom panel). Note that bottom panel in (A) is also 
representative of control littermates treated with isoproterenol, which are 
indistinguishable from Pax3 mutants treated with isoproterenol. (B) 
Echocardiogram images of E13.5 control and Pax3 mutant littermates (left and 
center panel). Right panel shows E16.5 Pax3 mutant treated with isoproterenol. 
Note that visualization of NT defects (exencephaly) and, thus, identification of 
Pax3 mutants is possible even at these early stages. (Echocardiography 
performed in collaboration with Dr. R. Mark Payne, MD).  
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Figure 18: Molecular analyses show molecular defects in Pax3d5/d5 mutants 
are rescued by isoproterenol treatment 
(A-B) Real-time PCR on E13.0 isolated heart mRNA from wildtype (wt), Pax3 
mutants (mut) and Pax3 mutants treated with isoproterenol (mut-iso), shows 
post-treatment normalization of initial misexpression in Pax3 mutants of 
upstream elements in the beta-adrenergic pathway (A) and downstream 
elements (B). (b1ar = beta-adrenergic receptor I, b2ar = beta-adrenergic receptor 
II, ac5 = adenylate cyclase V, ncx1 = sodium-calcium exchanger channel I, ryr2 = 
ryanodine receptor II). Each bar represents triplicates each of 3 pooled hearts, 
NS = not significant, ** = significant difference, p<0.05, *** = significant 
difference, p<0.01). (C) Western analyses of molecular targets important for 
cardiac contractility (Each band represents protein lysates from E13.0 isolated 
pooled hearts, n=4). (D) PKA activity assay on E12.5 whole embryo lysates from 
wildtype (wt), Pax3 mutants (mut) and Pax3 mutants treated with isoproterenol 
(mut-iso), shows post-treatment normalization of initial decreased PKA activity 
(measured in pmol/min/ug of protein). N=3, NS = not significant, ** = p<0.05. 
Note differences in response +/- addition of exogenous cAMP (5ul/reaction 
0.025mM).  
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 Chapter IV: Discourse 
 
1. Review 
 
The overall aim of my project was twofold. First, I wanted to determine the 
specific role of Pax3 in early NC specification and its effect on AAA and OFT 
remodeling. Second, I wanted to determine the potential secondary effect that 
migratory Pax3 mutant NC cells have on myocardial dysfunction and in utero 
lethality. To address this question, I used two mouse models with PTA/VSD but 
different lethality time points. My original hypothesis was that having Pax3 mutant 
CNC, albeit in fewer numbers (as is the case in Pax3 mutants), is more 
detrimental than complete absence of wildtype CNC (as is the case in the NC-
ablated model).  
 
My data suggests that, indeed, improperly specified NC cells in Pax3 mutants are 
unable to undergo proper differentiation at their sites of colonization. This lack of 
differentiation led to incorrect specification of NC cells fated along the 
sympathoadrenal lineage. As a result, NC-derived tissues responsible for Th 
expression and catecholamine synthesis were affected. On the other hand, my 
hypothesis assumed that there was a complete absence of migratory NC cells in 
Wnt1Cre/DTA mutants. However, based on analysis of the Wnt1Cre/DTA 
mutants, it is clear that there is an early subpopulation of TNC cells that escape 
Wnt1Cre-mediated ablation. So while Pax3 mutant NC cells were proven to be 
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detrimental, they are not more so than a complete absence, as originally 
postulated. More importantly, the underlying cause of lethality in Pax3 mutants 
was not due to a CNC-intrinsic factor as originally believed. Instead, it was 
secondary to lack of TNC-intrinsic factors.  
 
My data also suggests that catecholamines are not critically required for 
embryonic cardiac output prior to E10.5 (Figure 19). Ongoing studies are 
focusing on narrowing this time-window even further, as determining the 
minimum dosage and duration of treatment to get the most optimal result may 
have significant clinical implications. 
 
One easy to do follow up experiment will be to test whether pharmacological 
suppression of beta-adrenergic stimulation yields lethality around mid-gestation 
in control embryos. This could be achieved via bupranolol treatment, which is an 
effective antagonist of the beta-adrenergic receptor pathway [103]. However, I 
will have to be wary of initial results, as beta-blockers are also known to cause 
uterine contractions during late stage pregnancy and could affect embryonic 
survival independent of noradrenaline levels. 
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2. Other studies of relevance 
 
Previous research has shown that Msx2 is a direct downstream target of Pax3 in 
the neural tube [80]. Furthermore, Pax3 is required to repress Msx2, failure of 
which leads to a range of NC related defects. Specifically, Pax3 binds to an 8bp 
consensus sequence (GTCACACA) region located in a 660bp fragment of the 
Msx2 promoter [80]. More recently, another group working with Pax7 (a closely-
related protein to Pax3) identified a 5bp Pax7 core consensus motif (GTCAC). 
This was based on bioinformatic prediction of Pax7-ChIP consensus sites [108]. 
However, they did not specifically identify Msx2 as a downstream target of Pax7. 
Due to the identical nature of both consensus motifs and the close relation of 
Pax3 and Pax7, I sought to find out if Pax7 could play a similar repressive role on 
Msx2 in the NT. I did this through the use of luciferase constructs expressing the 
Msx2 promoter region, which were then transfected into NIH-3T3 cells.  
 
2.1. Summary of Materials and Methods 
Briefly, a pgl2 luciferase vector containing the Msx2 promoter sequence 
(pMsx2wt-luc) was used (gift from R. Maxson, USC). Site-specific mutagenesis 
was performed using the QuikChange Site Directed Mutagenesis Kit 
(Stratagene) according to the manufacturer's instructions to generate the pgl2 
luciferase vector containing the mutated Msx2 promoter sequence (pMsx2mut-
luc). To generate the mutated sequence (underlined) the following pair of primers 
were used: forward primer 5’ - GAG AGG TGC CAT CTT TTG CCC GAA 
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GGATATCG GCG AAT GTC CAC GGA TTG GAG GGC – 3’ and reverse primer 
5’ - GCC CTC CAA TCC GTG GAC ATT CGC CGATATCC TTC GGG CAA AAG 
ATG GCA CCT CTC - 3’. Mutagenesis was confirmed by sequencing.  
 
NIH-3T3 cells were grown and maintained in DMEM, supplemented with sodium 
pyruvate, glutamate, antibiotic mix (penicillin and streptomycin), and 10% fetal 
calf serum. Cells were transfected in triplicate using Transfectin Reagent (Biorad) 
according to the manufacturer's instructions in 6-well plates. Each well was 
transfected with a total of 4ug DNA (2ug effector vector + 2ug luciferase vector). 
As an internal control, each well was also transfected with 50ng of the Renilla 
luciferase vector (pRLCMV) in order to normalize for variation in transfection 
efficiency. After 48h, cells were washed briefly in PBS then lysed using 1x 
Passive Lysis Buffer (Promega) following manufacturer’s instructions. Cell 
samples were assayed for luciferase activity using the Dual Luciferase Reporter 
Assay system (Promega) on a Luminoskan Ascent microplate luminometer 
(ThermoScientific).  
 
Immunoblots were performed using mouse monoclonal anti-Pax3 and anti-Pax7 
antibodies (both obtained from Hybridoma Bank, University of Iowa); mouse 
monoclonal anti-β-tubulin antibody (Roche); and HRP-conjugated goat anti-
mouse IgG (Jackson Laboratories). Both the anti-Pax3 (1:1000) and anti-Pax7 
(1:1000) antibodies were incubated overnight at 4C. Anti-β-tubulin (1:10000) and 
goat anti-mouse (1:5000) antibodies were incubated for 1h at room temperature. 
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Antibodies were detected using the enhanced chemiluminescence (ECL) plus 
detection system (Amersham). Densitometry of immunoreactive bands was 
performed using Image J 1.37v (NIH). 
 
2.2. Summary of Results and Discussion 
My luciferase results suggest that Pax7 is capable of repressing Msx2, albeit not 
as well as Pax3 (Figure 20). It also appears to do so cooperatively with Pax3 
based on results from co-transfections of both Pax3 and Pax7. However, the 
mechanism by which this occurs is still not clear. One possible mechanism could 
be that that both Pax3 and Pax7 compete with each other to bind to the Msx2 
promoter at the consensus site with Pax3 being a stronger competitor. 
Alternatively, they may both have similar binding affinity with Pax3 being the 
stronger repressor. The fact that Pax7, in the absence of Pax3, fails to repress 
Msx2 promoter activity as efficiently as Pax3 suggests that the latter may be the 
case. If so, it will be interesting to determine whether or not both Pax3/7 can 
repress Msx2 as part of a single complex or if they bind Msx2 exclusively 
independent of each other. Previous research has already shown that both Pax3 
and Pax7 can cooperatively heterodimerize with each other on palindromic 
homeodomain binding sequences [109]. However, since the consensus motifs 
through which both transcription factors bind Msx2 (GTCACaca) is not 
palindromic, I believe this suggests a cooperative but independent role of both 
Pax3 and Pax7 in repressing Msx2.  
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3. Future studies 
 
Based on preliminary results from luciferases experiments mentioned above, 
elucidating the role of Pax7 (if any) on in utero lethality and cardiac function may 
be useful. There is already some suggestion that both Pax3 and Pax7 may share 
similar roles and that Pax3 may function cooperatively with Pax7 [110, 111]. 
Thus, Pax7 may be capable of regulating myocardial homeostasis via Msx2 
regulation or some other common downstream target. To address this, we 
already have both Pax3 and Pax7 null mice. Since Pax7 null mice are viable to 
birth (Mansouri, 1996), it is clear that Pax7 independently is not important in 
utero lethality. However, this does not rule out the possibility that Pax7 in 
conjunction with Pax3 may play a role in embryonic survival. To test this, we plan 
to cross the previously described (Chapter II) Pax3f/d5/Wnt1Cre conditional 
knockout mice (which are viable) unto a Pax7 happloinsufficient background (i.e., 
Pax7+/- and Pax7-/-). We will then determine if in utero lethality is observed in 
the normally viable Pax3f/d5/Wnt1Cre conditional mutants, when Pax7 levels are 
reduced. If we observe lethality, we will perform similar analyses to determine 
effects on norepinephrine levels and the possibility of pharmacological rescue. 
 
Another direction worth pursuing is based on recent hyperoxia studies in mice, 
which show that high maternal oxygen can rescue catecholamine-deficient 
embryos [107]. This occurs due to an increase in blood oxygen levels that is 
delivered to the developing embryo. This results in increased embryonic heart 
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rate and overall improved cardiac output. Based on these studies, we propose to 
test whether an increase in maternal oxygen levels can similarly rescue our Pax3 
mutants by directly stimulating heart function. We believe this may be an 
important follow up study to identify alternative approaches, which can be used to  
rescue impaired embryonic cardiac function. 
  
Figure 19: Critical temporal requirement of catecholamines during 
embryonic development. Adapted from [112].  
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Figure 20: Pax7 can substitute role of Pax3 in suppression of Msx2 
 (A) Relative fold repression of luciferase activity with empty Pcdna vector control 
nominally set to 1. Both Pax3 and Pax7 independently and cooperatively repress 
the 660bp Msx2 promoter containing consensus site (shaded bars, p<0.05). 
However, they fail to repress the 660bp Msx2 promoter containing the 8bp 
mutated sequence (dashed bars; p>0.05). Each bar represents 2ug total 
transfected DNA of empty Pcdna control, Pax3, Pax7 respectively. Also included 
are combined transfections of 1ug each of Pax3 and Pax7 indicated by 
½(pax3+7). Data are expressed as relative fold of luciferase activity to empty 
Pcdna vector control. Data represents the average of n = 6 ± standard error of 
the mean for each set. (B) Western blots of cell lysates from respective wells 
transfected with 2ug empty Pcdna control (lane 1), 2ug Pax3 (lane 2), 2ug Pax7 
(lane 3), 1ug Pax3 + 1ug Pax7 (lane 4); β-tubulin was used as a loading control. 
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